===========================================================================

                                UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                           WASHINGTON, D.C.  20549
                   _______________________________________

                                  FORM 10-Q

           [X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                   OF THE SECURITIES EXCHANGE ACT OF 1934

              For the Quarterly Period Ended September 30, 2004

           [ ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
                   OF THE SECURITIES EXCHANGE ACT OF 1934

                 For the Transition Period from ____ to ____
                   _______________________________________

                         Commission File No. 0-12942

                             PARLEX CORPORATION
           (Exact Name of Registrant as Specified in Its Charter)

      Massachusetts                                             04-2464749
---------------------------------------------------------------------------
(State of incorporation)                                        (I.R.S. ID)

               One Parlex Place, Methuen, Massachusetts  01844
            (Address of Principal Executive Offices)   (Zip Code)

                                978-685-4341
            (Registrant's Telephone Number, Including Area Code)


Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act 
of 1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days.
                             Yes [X]      No [ ]

Indicate by check mark whether the registrant is an accelerated filer (as 
defined in Rule 12b-2 of the Exchange Act).
                             Yes [ ]      No [X]

The number of shares outstanding of the registrant's common stock as of 
November 8, 2004 was 6,449,056 shares.

===========================================================================





                             PARLEX CORPORATION
                             ------------------

                                 FORM 10 - Q
                                 -----------

                                    INDEX
                                    -----


Part I - Financial Information                                         Page
                                                                       ----

Item 1.  Unaudited Condensed Consolidated Financial Statements:

         Condensed Consolidated Balance Sheets - September 30, 2004
         and June 30, 2004                                               3

         Condensed Consolidated Statements of Operations - For
         the Three Months Ended September 30, 2004 and September 
         28, 2003                                                        4

         Condensed Consolidated Statements of Cash Flows - For
         the Three Months Ended September 30, 2004 and September
         28, 2003                                                        5

         Notes to Unaudited Condensed Consolidated Financial 
         Statements                                                      6

Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations                            18

Item 3.  Quantitative and Qualitative Disclosures About Market 
         Risk                                                           35

Item 4.  Controls and Procedures                                        36

Part II - Other Information

Item 6.  Exhibits                                                       38

Signatures                                                              39

Exhibit Index                                                           40


  2


PARLEX CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS
---------------------------------------------------------------------------



ASSETS                                  September 30, 2004    June 30, 2004
                                            (unaudited)

                                                        
CURRENT ASSETS:
  Cash and cash equivalents                $  2,476,287       $  1,626,275
  Accounts receivable - net                  25,860,262         21,999,646
  Inventories - net                          22,570,748         20,326,134
  Refundable income taxes                       291,823            380,615
  Deferred income taxes                          42,958             42,958
  Other current assets                        2,234,581          2,381,471
                                           ------------       ------------

      Total current assets                   53,476,659         46,757,099
                                           ------------       ------------

PROPERTY, PLANT AND EQUIPMENT - NET          44,364,560         44,979,740

INTANGIBLE ASSETS - NET                          32,014             32,746

GOODWILL - NET                                1,157,510          1,157,510

DEFERRED INCOME TAXES                            40,000             40,000

OTHER ASSETS - NET                            2,114,313          2,283,136

TOTAL                                      $101,185,056       $ 95,250,231
                                           ============       ============

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
  Current portion of long-term debt        $ 15,404,125       $ 12,861,077
  Accounts payable                           20,557,461         16,479,547
  Dividends payable                              67,582             39,317
  Accrued liabilities                         4,299,883          4,277,587
                                           ------------       ------------

      Total current liabilities              40,329,051         33,657,528
                                           ------------       ------------

LONG-TERM DEBT                               10,594,598         10,534,679
                                           ------------       ------------

OTHER NONCURRENT LIABILITIES                    909,421          1,025,091
                                           ------------       ------------

MINORITY INTEREST IN PARLEX SHANGHAI            611,114            570,963
                                           ------------       ------------

COMMITMENTS AND CONTINGENCIES 
STOCKHOLDERS' EQUITY:
  Preferred stock                                40,625             40,625
  Common stock                                  643,593            663,281
  Accrued interest payable in common
   stock                                         68,502             87,924
  Additional paid-in capital                 65,981,801         66,979,397
  Accumulated deficit                       (18,570,034)       (17,771,307)
  Accumulated other comprehensive
   income                                       576,385            499,675
  Less treasury stock, at cost                        -         (1,037,625)
                                           ------------       ------------

      Total stockholders' equity             48,740,872         49,461,970
                                           ------------       ------------

TOTAL                                      $101,185,056       $ 95,250,231
                                           ============       ============


See notes to unaudited condensed consolidated financial statements.


  3


PARLEX CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)
---------------------------------------------------------------------------



                                                             Three Months Ended
                                                   September 30, 2004    September 28, 2003

                                                                      
REVENUES:                                             $31,487,405           $19,704,431
                                                      -----------           -----------

COSTS AND EXPENSES:
  Cost of products sold                                26,800,499            17,472,246
  Selling, general and administrative expenses          4,608,647             3,740,366
                                                      -----------           -----------

     Total costs and expenses                          31,409,146            21,212,612
                                                      -----------           -----------

OPERATING INCOME (LOSS)                                    78,259            (1,508,181)

INTEREST AND NON OPERATING INCOME (EXPENSE)
Interest income                                             6,361                 4,595
Interest expense                                         (764,351)             (532,651)
Non operating income                                            -                11,742
Non operating expense                                     (25,989)                 (218)
                                                      -----------           -----------

LOSS BEFORE INCOME TAXES AND MINORITY INTEREST           (705,720)           (2,024,713)

PROVISION FOR INCOME TAXES                                (52,856)                    -
                                                      -----------           -----------

LOSS BEFORE MINORITY INTEREST                            (758,576)           (2,024,713)

MINORITY INTEREST                                         (40,151)              (62,318)
                                                      -----------           -----------

NET LOSS                                                 (798,727)           (2,087,031)

PREFERRED STOCK DIVIDENDS                                 (67,582)                    -
                                                      -----------           -----------

NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS          $  (866,309)          $(2,087,031)
                                                      -----------           -----------

BASIC AND DILUTED LOSS PER SHARE                      $     (0.13)          $     (0.33)
                                                      -----------           -----------

WEIGHTED AVERAGE SHARES - BASIC AND DILUTED             6,435,933             6,312,216
                                                      ===========           ===========


See notes to unaudited condensed consolidated financial statements.


  4


PARLEX CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
---------------------------------------------------------------------------



                                                             Three Months Ended
                                                   September 30, 2004    September 28, 2003

                                                                      
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss                                             $   (798,727)          $ (2,087,031)
                                                     ------------           ------------
Adjustments to reconcile net loss to net cash
provided by (used for) operating activities:
Non-cash operating items:
Depreciation of property, plant and equipment           1,392,793              1,658,636
Amortization of deferred loss on sale-leaseback,
 deferred financing costs and intangible assets           292,611                143,221
Interest payable in common stock                           68,502                 73,195
Minority interest                                          40,151                 62,318
Changes in current assets and liabilities:
Accounts receivable - net                              (3,862,804)            (2,623,007)
Inventories                                            (2,251,206)            (2,006,270)
Refundable taxes                                           88,792                144,776
Other assets                                              153,533               (108,796)
Accounts payable and accrued liabilities                3,889,109             (1,271,071)
                                                     ------------           ------------
Net cash used for operating activities                   (987,246)            (6,014,029)
                                                     ------------           ------------

CASH FLOWS FROM INVESTING ACTIVITIES:
  Deposit received for sale of China land use
   rights                                                       -                974,964
  Additions to property, plant and equipment
 and other assets                                        (594,026)              (280,611)
                                                     ------------           ------------
Net cash (used for) provided by  investing
 activities                                              (594,026)               694,353
                                                     ------------           ------------

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from bank loans                               24,960,000              7,502,960
Payment of bank loans                                 (22,431,426)            (7,846,834)
Payment of capital lease                                  (26,240)                     -
Payment of Methuen sale-leaseback financing
 obligation                                               (60,993)               (74,974)
Cash received for interest on sale-leaseback
 note receivable                                           32,250                      -
Dividend paid to series A preferred stock
 investors                                                (39,317)                     -
Proceeds from convertible note, net of costs                    -              5,509,984
                                                     ------------           ------------
Net cash provided by financing activities               2,434,274              5,091,136
                                                     ------------           ------------

EFFECT OF EXCHANGE RATE CHANGES ON CASH                    (2,990)                 8,324
                                                     ------------           ------------

NET INCREASE (DECREASE) IN CASH AND CASH
 EQUIVALENTS                                              850,012               (220,216)

CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR            1,626,275              1,513,523
                                                     ------------           ------------

CASH AND CASH EQUIVALENTS, END OF PERIOD             $  2,476,287           $  1,293,307
                                                     ============           ============

SUPPLEMENTARY DISCLOSURE OF NONCASH  FINANCING AND
 INVESTING ACTIVITIES:
  Property, plant, equipment and other asset
   purchases financed under capital lease,
   long-term debt and accounts payable               $    187,120           $    242,874
                                                     ============           ============
  Issuance of warrants in connection with
   issuance of convertible debt                      $          -           $  1,139,252
                                                     ============           ============
  Beneficial conversion feature associated
   with convertible debt                             $          -           $  1,035,016
                                                     ============           ============
  Interest receivable associated with Methuen
   sale-leaseback financing obligation               $          -           $     33,125
                                                     ============           ============
  Interest payable in common stock                   $     87,924           $          -
                                                     ============           ============
  Accrual of preferred stock dividends               $     67,582           $          -
                                                     ============           ============


See notes to unaudited condensed consolidated financial statements.


  5


PARLEX CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
---------------------------------------------------------------------------

1.    Basis of Presentation
      ---------------------

The condensed consolidated financial statements include the accounts of 
Parlex Corporation, its wholly owned subsidiaries ("Parlex" or the 
"Company") and its 90.1% investment in Parlex (Shanghai) Circuit Co., Ltd. 
("Parlex Shanghai"). The financial statements as reported in Form 10-Q 
reflect all adjustments that are, in the opinion of management, necessary 
to present fairly the financial position as of September 30, 2004 and the 
results of operations and cash flows for the three months ended September 
30, 2004 and September 28, 2003.  All adjustments made to the interim 
financial statements included all those of a normal and recurring nature.   
The results for interim periods are not necessarily indicative of results 
that may be expected for any other interim period or for the full year.

This filing should be read in conjunction with the Company's annual report 
on Form 10-K for the year ended June 30, 2004.

As shown in the consolidated financial statements, the Company incurred net 
losses of $798,727 and $2,087,031 and used $987,246 and $6,014,029 of cash 
in operations for the three months ended September 30, 2004 and September 
28, 2003, respectively.  In addition, the Company had an accumulated 
deficit of $18,570,034 at September 30, 2004.  As of September 30, 2004, 
the Company had a cash balance of $2,476,287.

In response to the worldwide downturn in the electronics industry, 
management has taken a series of actions to reduce operating expenses and 
to restructure operations, consisting primarily of reductions in workforce 
and consolidation of manufacturing operations.  During 2004, the Company 
transferred its high volume automated surface mount assembly line from its 
Cranston, Rhode Island facility to China.  In August 2004, the Company 
announced a new strategic relationship with Delphi Corporation to supply 
all multilayer flex and rigid flex circuits that were previously 
manufactured by Delphi Corporation in its Irvine, California facility.  
Management continues to implement plans to control operating expenses, 
inventory levels, and capital expenditures as well as manage accounts 
payable and accounts receivable to enhance cash flow and return the Company 
to profitability. Management's plans include the following actions: 1) 
continuing to consolidate manufacturing facilities; 2) continuing to 
transfer certain manufacturing processes from the Company's domestic 
operations to lower cost international manufacturing locations, primarily 
those in the People's Republic of China; 3) expanding the Company's 
products in the home appliance, laptop computer, medical, military and 
aerospace, and electronic identification markets; 4) continuing to monitor 
general and administrative expenses; and 5) continuing to evaluate 
opportunities to improve capacity utilization by either acquiring 
multilayer flexible circuit businesses or entering into strategic 
relationships for their production.

In fiscal years 2003 and 2004, management entered into a series of 
alternative financing arrangements to partially replace or supplement those 
currently in place in order to provide the Company with financing to 
support its current working capital needs.  Working capital requirements, 
particularly those to support the growth in the Company's China operations, 
consumed $10.4 million of a total $11.4 million of cash used in operations 
during 2004.  In September 2004, the Company secured a new $5 million asset 
based working capital agreement with the Bank of China which provides 
standalone financing for its China operations. In addition, in May and June 
of 2004 the Company received net proceeds of approximately $2.95 million 
from the sale of its Series A convertible preferred stock.  Management 
continues to evaluate alternative financing opportunities to further 
improve its liquidity and to fund working capital needs.  Management 
believes that the Company's cash on hand and the cash expected to be 
generated from operations will be sufficient to enable the Company to meet 
its operating obligations at least through September 2005.  If the Company 


  6


requires additional or new external financing to repay or refinance its 
existing financing obligations or fund its working capital requirements, 
the Company believes that it will be able to obtain such financing.  
Failure to obtain such financing may have a material adverse impact on the 
Company's operations.  At September 30, 2004, the Company was in compliance, 
and expects to remain in compliance, with all of its financial covenants 
associated with its financing arrangements.

2.    Inventories
      -----------

Inventories of raw materials are stated at the lower of cost (first-in, 
first-out) or market.  Work in process and finished goods are valued as a 
percentage of completed cost, not in excess of net realizable value.  Raw 
material, work in process and finished goods inventory associated with 
programs cancelled by customers are fully reserved for as obsolete.  
Reductions in obsolescence reserves are recognized when the underlying 
products are disposed of or sold.  Inventories consisted of:



                                          September 30,       June 30,
                                              2004              2004

                                                      
Raw materials                              $10,255,636      $ 8,729,132
Work in process                             10,211,249        9,444,722
Finished goods                               5,121,746        5,049,796
                                           -----------      -----------
Total cost                                  25,588,631       23,223,650
Reserve for obsolescence                    (3,017,883)      (2,897,516)
                                           -----------      -----------
Inventory, net                             $22,570,748      $20,326,134
                                           ===========      ===========


3.    Property, Plant and Equipment
      -----------------------------

Property, plant and equipment are stated at cost and are depreciated using 
the straight-line method over their estimated useful lives. Property, plant 
and equipment consisted of:




                                          September 30,       June 30,
                                              2004              2004

                                                      
Land and land improvements                 $    589,872     $    589,872
Buildings                                    18,543,295       18,543,295
Machinery and equipment                      63,828,002       64,348,226
Leasehold improvements and other              6,605,973        6,695,173
Construction in progress                      3,856,584        2,902,141
                                           ------------     ------------

Total cost                                   93,423,726       93,078,707
Less: accumulated depreciation              (49,059,166)     (48,098,967)
                                           ------------     ------------
Property, plant and equipment, net         $ 44,364,560     $ 44,979,740
                                           ============     ============



  7


4.    Intangible Assets
      -----------------

Intangible assets consisted of:



                                                 September 30,    June 30,
                                                    2004            2004

                                                            
Patents                                            $ 58,560       $ 58,560
Accumulated amortization                            (26,546)       (25,814)
                                                   --------       --------

Intangible assets, net                             $ 32,014       $ 32,746
                                                   ========       ========


The Company has reassessed the remaining useful lives of the intangible 
assets at September 30, 2004 and determined the useful lives are 
appropriate in determining amortization expense.  Amortization expense for 
the three months ended September 30, 2004 and September 28, 2003 was $732 
and $2,449, respectively. 

5.    Other Assets
      ------------

Other assets consisted of: 



                                               September 30,     June 30,
                                                  2004             2004

                                                          
Deferred loss on sale-leaseback of Poly-Flex
 Facility, net                                  $1,018,915      $1,087,606
Deferred financing costs on sale-leaseback
 of Methuen facility (see Note 7)                  361,700         361,700
Deferred financing costs on the Loan and
 Security Agreement (see Note 7)                   292,722         267,722
Deferred financing costs on Convertible
 Subortinated Note (see Note 7)                    673,930         673,930
Other                                              130,060         160,650
                                                ----------      ----------
Total cost                                       2,477,327       2,551,608
Less: accumulated amortization                    (363,014)       (268,472)
                                                ----------      ----------
Total Other Assets, net                         $2,114,313      $2,283,136
                                                ==========      ==========


In June 2003, Poly-Flex sold its operating facility in Cranston, Rhode 
Island for a total purchase price of $3,000,000 in cash. Under the terms of 
the Purchase and Sale Agreement, Poly-Flex entered into a five-year lease 
of the Poly-Flex Facility with the buyer. The Company did not record an 
immediate loss on the transaction since the fair value of the Poly-Flex 
Facility exceeded the net book value of the facility at the time of sale. 
However, approximately $1,374,000 of excess net book value over the sales 
price was recorded as a deferred loss and included in Other Assets - Net on 
the condensed consolidated balance sheets. The deferred loss is being 
amortized to lease expense over the five-year lease term.  Amortization of 
the deferred loss, reported as a component of rent expense, was $69,000 for 
the three months ended September 30, 2004 and September 28, 2003.

Amortization of deferred financing costs was $95,000 and $57,000 for the 
three months ended September 30, 2004 and September 28, 2003, respectively.


  8


6.    Accrued Liabilities - Facility Exit Costs
      -----------------------------------------

The following is a summary of the facility exit costs activity during the 
three months ended September 30, 2004:



                                              Facility       FY2005        Facility
                                             Exit Costs     Activity       Exit Costs
                                              Accrued         Cash          Accrued
                                           June 30, 2004    Payments    September 30, 2004
                                           -------------    --------    ------------------

                                                                   
Total Facility refurbishment costs           $136,952       $(3,500)        $133,452


The remaining accrued facility exit costs at September 30, 2004 represent 
the estimated costs to refurbish the facility.  The Company expects the 
balance of accrued facility exit costs at September 30, 2004 to be paid 
within the next three months.

7.    Long-term Debt
      --------------

Long-term debt consisted of:



                                              September 30,       June 30,
                                                 2004               2004

                                                          
Loan and Security Agreement                    $ 7,354,890      $ 3,618,091
Parlex Shanghai term notes                       7,662,567        8,870,792
Finance obligation on sale-leaseback of
 Methuen Facility                                5,880,501        5,909,245
Convertible Subordinated Note                    4,533,728        4,404,351
Other                                              567,037          593,277
                                               -----------      -----------
Total long-term debt                            25,998,723       23,395,756

Less: current portion of long-term debt         15,404,125       12,861,077
                                               -----------      -----------

Long-term debt                                 $10,594,598      $10,534,679
                                               ===========      ===========


A summary of the current portion of our long term debt described above is 
as follows:



                                              September 30,       June 30,
                                                 2004               2004

                                                          
Loan and Security Agreement                    $ 7,354,890      $ 3,618,091
Parlex Shanghai term notes                       7,662,567        8,870,792
Finance obligation on sale-leaseback
 of Methuen Facility                               276,027          263,849
Other                                              110,641          108,345
                                               -----------      -----------

Total current portion of long-term debt        $15,404,125      $12,861,077
                                               ===========      ===========


Loan and Security Agreement ("the Loan Agreement") - The Company executed 
the Loan Agreement with Silicon Valley Bank on June 11, 2003. The Loan 
Agreement provided Silicon Valley Bank with a secured interest in 
substantially all of the Company's assets. The Company may borrow up to 
$10,000,000, based on a borrowing base of eligible accounts receivable. 
Borrowings may be used for working capital purposes only. The Loan 
Agreement allows the Company to issue letters of credit, enter into foreign 


  9


exchange forward contracts and incur obligations using the bank's cash 
management services up to an aggregate limit of $1,000,000, which reduces 
the Company's availability for borrowings under the Loan Agreement.  As of 
September 30, 2004, the Company had a $1,000,000 letter of credit 
outstanding.  The Loan Agreement contains certain restrictive covenants, 
including but not limited to, limitations on debt incurred by its foreign 
subsidiaries, acquisitions, sales and transfers of assets, and prohibitions 
against cash dividends, mergers and repurchases of stock without prior bank 
approval.  The Loan Agreement also has financial covenants, which among 
other things require the Company to maintain $750,000 in minimum cash 
balances or excess availability under the Loan Agreement.

On September 23, 2003, the Company executed a Modification Agreement (the 
"Modification Agreement") with Silicon Valley Bank.  The Modification 
Agreement increased the interest rate on borrowings to the bank's prime 
rate plus 1.5% and amended the financial covenants.  On February 18, 2004, 
the Company executed a Second Modification Agreement (the "Second 
Modification Agreement") with Silicon Valley Bank.  The Second Modification 
Agreement removed the fixed charge coverage ratio from the Loan Agreement 
and required the Company to report earnings before income taxes, 
depreciation and amortization ("EBITDA") of at least $50,000 on a three 
month trailing basis, beginning January 31, 2004.  The minimum EBITDA 
requirement was increased to $250,000 at June 30, 2004.  The Second 
Modification Agreement increased the interest rate on borrowings to the 
bank's prime rate plus 2.0% (decreasing to prime plus 1.25% after two 
consecutive quarters of positive operating income and to prime plus 0.75% 
after two consecutive quarters of positive net income, respectively) and 
amended the financial covenants.  On March 28, 2004, the Company entered 
into a Third Loan Modification Agreement with Silicon Valley Bank, which 
permitted certain of the Company's subsidiaries to increase the amount of 
indebtedness they could incur from $8 million to $13 million, so long as 
such indebtedness was without recourse to Parlex and its principal 
subsidiaries.  On May 10, 2004, the Company executed a Fourth Loan 
Modification Agreement (the "Fourth Modification Agreement") with Silicon 
Valley Bank. The Fourth Modification Agreement changed the EBITDA 
requirement to $1.00 as of April 30, 2004 and May 31, 2004 and $250,000 on 
a three month trailing basis beginning June 30, 2004. On June 25, 2004, the 
Company executed a Fifth Loan Modification Agreement (the "Fifth 
Modification Agreement") with Silicon Valley Bank. The Fifth Modification 
Agreement permitted certain of the Company's subsidiaries to borrow up to 
$5,000,000 in the aggregate from the Bank of China. The Fifth Modification 
Agreement increased the interest rate on borrowings to the bank's prime 
rate (4.75% at September 30, 2004) plus 2.25% (decreasing to prime plus 
1.25% after two consecutive quarters of positive operating income and to 
prime plus 0.75% after two consecutive quarters of positive net income, 
respectively).  On September 24, 2004, the Company executed a Sixth Loan 
Modification Agreement with Silicon Valley Bank to extend the maturity date 
of the Loan Agreement from June 10, 2005 to July 11, 2005.  All other terms 
and conditions of the Loan Agreement remain the same. As of September 30, 
2004, the Company was in compliance with its financial covenants.  At 
September 30, 2004, the Company had available borrowing capacity under the 
Loan Agreement of approximately $1.6 million.  As the available borrowing 
capacity exceeded $750,000 at September 30, 2004, none of the Company's 
cash balance was subject to restriction at September 30, 2004.

The Loan Agreement includes both a subjective acceleration clause and a 
lockbox arrangement that requires all lockbox receipts to be used to pay 
down the revolving credit borrowings.  Accordingly, borrowings under the 
Loan Agreement are classified as current liabilities in the accompanying 
consolidated balance sheets as of September 30, 2004 and June 30, 2004 as 
required by Emerging Issues Task Force Issue No. 95-22, " Balance Sheet 
Classification of Borrowings Outstanding Under Revolving Credit Agreements 
that include both a Subjective Acceleration Clause and a Lockbox 
Arrangement".  However, such borrowings will be excluded from current 
liabilities in future periods and considered long-term obligations if: 1) 
such borrowings are refinanced on a long-term basis, 2) the subjective 
acceleration terms of the Loan Agreement are modified, or 3) such 
borrowings will not require the use of working capital within one year.


  10


Parlex Shanghai Term Notes - On August 20, 2003, Parlex Shanghai entered 
into a short-term bank note for 1.2 million, due August 20, 2004, bearing 
interest at 5.841% and guaranteed by Parlex Interconnect.  The note was 
retired in August 2004. On December 15, 2003, Parlex Shanghai entered into 
a short-term bank note, due December 15, 2004, bearing interest at 5.31% 
and guaranteed by Parlex Interconnect.  Amounts outstanding under this 
short-term note total $605,000 as of September 30, 2004.  On January 14, 
2004, Parlex Shanghai entered into two short-term bank notes, due October 
12, 2004 for $725,000 and November 10, 2004 for $1.0 million bearing 
interest at 5.31% and guaranteed by Parlex Interconnect.  On October 11, 
2004 Parlex Shanghai renewed the bank note due October 12, 2004 for an 
additional six months.  The Company intends on renewing the bank note due 
November 10, 2004 at similar terms and conditions.  On February 13, 2004 
and March 2, 2004, Parlex Shanghai entered into two short-term bank notes, 
due January 12, 2005 and March 1, 2005, bearing interest at 5.31% and 
guaranteed by Parlex Interconnect.  Amounts outstanding under these 
short-term notes as of September 30, 2004 totaled $3.8 million.  On March 
5, 2004, Parlex Shanghai entered into a short-term bank note, due January 5, 
2005, bearing interest at LIBOR plus 2.5% and guaranteed by the Company's 
subsidiary Parlex Asia Pacific Ltd, ("Parlex Asia").  Amounts outstanding 
under this short-term note as of September 30, 2004 total $1.5 million.  
The Company believes that it will be able to obtain the necessary 
refinancing of its Parlex Shanghai short term debt because of the Company's 
history of successfully refinancing its short term Chinese borrowings and 
its rapidly improving Chinese operating results. 

Parlex Interconnect Term Notes - On October 28, 2004, Parlex Interconnect 
entered into a $605,000 short-term bank note, due October 27, 2005, bearing 
interest at 5.31% and guaranteed by Parlex Shanghai.

Parlex Asia Banking Facility - On September 15, 2004, Parlex Asia entered 
into an agreement with the Bank of China for a $5 million banking facility 
guaranteed by Parlex. Under the terms of the banking facility, Parlex Asia 
may borrow up to $5 million based on a borrowing base of eligible account 
receivables. The banking facility bears interest at LIBOR plus 2%.  The 
Company anticipates utilizing borrowings from this financing for the 
refinancing of certain Parlex Shanghai term notes or for working capital 
needs.

Finance Obligation on Sale Leaseback of Methuen Facility - In June 2003, 
Parlex entered into a sale-leaseback transaction pursuant to which it sold 
its corporate headquarters and manufacturing facility located in Methuen, 
Massachusetts (the "Methuen Facility") for a purchase price of $9,000,000.  
The purchase price consisted of $5,350,000 in cash at the closing, a 
promissory note in the amount of $2,650,000 (the "Note") and up to 
$1,000,000 in additional cash under the terms of an Earn Out Clause. In 
June 2004, Parlex received $750,000 reducing the principal balance of the 
promissory note to $1,900,000.  In connection with the transaction, Parlex 
simultaneously entered into a lease agreement relating to the Methuen 
Facility with a minimum lease term of 15 years.

As the repurchase option contained in the lease and the receipt of the Note 
from the buyer provide Parlex with a continuing involvement in the Methuen 
Facility, Parlex has accounted for the sale-leaseback of the Methuen 
Facility as a financing transaction. Accordingly, the Company continues to 
report the Methuen Facility as an asset and continues to record 
depreciation expense. The Company records all cash received under the 
transaction as a finance obligation.  The Note and related interest 
thereon, and the $1,000,000 in additional cash under the terms of an Earn 
Out Clause, will be recorded as an increase to the finance obligation as 
cash payments are received. The Company records the principal portion of 
the monthly lease payments as a reduction to the finance obligation and the 
interest portion of the monthly lease payments is recorded as interest 
expense. The closing costs for the transaction have been capitalized and 
are being amortized as interest expense over the initial 15-year lease 
term. Upon expiration of the repurchase option (June 30, 2015), the Company 
will reevaluate its accounting to determine whether a gain or loss should 
be recorded on this sale-leaseback transaction. 

Convertible Subordinated Notes - On July 28, 2003, Parlex sold an aggregate 
$6,000,000 of its 7% convertible subordinated notes (the "Notes") with 
attached warrants to several institutional investors. The 


  11


Company received net proceeds of approximately $5.5 million from the 
transaction, after deducting approximately $500,000 in finders' fees and 
other transaction expenses. Net proceeds were used to pay down amounts 
borrowed under the Company's Loan Agreement and utilized for working 
capital needs. No principal payments are due until maturity on July 28, 
2007. The Notes are unsecured.

The Notes bear interest at a fixed rate of 7%, payable quarterly in shares 
of Parlex common stock. The number of shares of common stock to be issued 
is calculated by dividing the accrued quarterly interest by a conversion 
price, which was initially established at $8.00 per share.  The conversion 
price is subject to adjustment in the event of stock splits, dividends and 
certain combinations.

Interest expense is recorded quarterly based on the fair value of the 
common shares issued. Accordingly, interest expense may fluctuate from 
quarter to quarter. The Company has concluded that the interest feature 
does not constitute an embedded derivative as it does not currently meet 
the criteria for classification as a derivative.

The Company recorded accrued interest payable on the Notes of $68,502 
within stockholders' equity at September 30, 2004, as the interest is 
required to be paid quarterly in the form of common stock.  Based on the 
conversion price of $8.00 per common share, the Company issued a total of 
48,717 shares of common stock in October 2003, January, April and July 2004 
in satisfaction of previously recorded interest and issued 13,123 shares of 
common stock in October 2004 as payment for the interest accrued at 
September 30, 2004.

The Notes contain a beneficial conversion feature reflecting an effective 
initial conversion price that was less than the fair market value of the 
underlying common stock on July 28, 2003. The fair value of the beneficial 
conversion feature was approximately $1,035,000, which has been recorded as 
an increase to additional paid-in capital and as an original issue discount 
on the Notes that is being amortized to interest expense over the four year 
life of the Notes.

After two years from the date of issuance, the Company has the right to 
redeem all, but not less than all, of the Notes at 100% of the remaining 
principal of Notes then outstanding, plus all accrued and unpaid interest, 
under certain conditions. After three years from the date of issuance, the 
holder of any of the Notes may require the Company to redeem the Notes in 
whole, but not in part. Such redemption shall be at 100% of the remaining 
principal of such Notes, plus all accrued and unpaid interest. In the event 
of a Change in Control (as defined therein), the holder has the option to 
require that the Notes be redeemed in whole (but not in part), at 120% of 
the outstanding unpaid principal amount, plus all unpaid accrued interest.

8.    Stockholders' Equity
      --------------------

Series A Convertible Preferred Stock - On May 7, 2004 and June 8, 2004, the 
Company completed a private placement of 40,625 shares of Series A 
Convertible Preferred Stock (the "Series A Preferred Stock") and warrants 
entitling holders to purchase 203,125 shares of common stock at $80.00 per 
unit for proceeds of approximately $2,950,000, net of issuance costs of 
approximately $300,000. In connection with the private placement, investors 
received rights to purchase additional shares of the Series A Preferred 
Stock (the "Over-Allotment Right"). The warrants are exercisable 
immediately at an exercise price of $8.00 per share (subject to adjustment 
for certain dilutive events) and expire on May 7, 2007 and June 8, 2007. 
The Over-Allotment Right allows each investor to purchase additional shares 
of Series A Preferred Stock in an amount up to 20% of the original purchase 
and on the same terms as the original purchase. The Over-Allotment right 
expires on November 7, 2004 and December 8, 2004. 

The Series A Preferred Stock is redeemable at the option of the Company on 
the third anniversary of the closing, upon 30 days notice to the holders, 
in whole but not in part, at $80.00 per share (subject to adjustment for 
certain dilutive events) together with all accrued but unpaid dividends to 
the redemption 


  12


date.  The Series A Preferred Stockholders have no voting rights, except 
with respect to certain limited matters that directly impact the Series A 
Preferred Stock. 

Each share of Series A Preferred Stock is only convertible into 10 shares 
of common stock at the option of the holder at any time, until 20 days 
following the date on which the Company first mails its notice of 
redemption, if any.  The initial conversion price of $8.00 is adjusted for 
certain dilutive events.  The Series A Preferred Stock is subject to 
mandatory conversion if the Company's common stock price closes above 
$12.00 per share for twenty (20) consecutive trading days. 

The Series A Preferred Stock is entitled to receive cumulative dividends at 
an annual rate of 8.25% ($6.60 per share), payable quarterly in cash or 
shares of common stock or a combination of cash and stock at the election 
of the Company.  In the event the Company does not exercise its right to 
redeem the Series A Preferred Stock on the third anniversary, the dividend 
rate shall increase to 14% ($11.20 per share) per annum payable quarterly 
exclusively in cash. 

The Preferred Stock also entitles the holders thereof to a preferential 
payment in the event of the Company's voluntary or involuntary liquidation, 
dissolution or winding up.  Specifically, in any such case, the holders of 
Preferred Stock shall be entitled to be paid, out of the Company's assets 
that are available for distribution to our shareholders, the sum of $80.00 
per share of Preferred Stock held or $3,250,000, plus all accrued and 
unpaid dividends thereon, prior to any payments being made to holders of 
our common stock.  The $80.00 per share liquidation preference payment 
amount is subject to equitable adjustment for stock splits, stock 
dividends, combinations, reorganizations and similar events effecting the 
shares of Preferred Stock.

As the original price of $80.00 included a share of Series A Preferred 
Stock, a warrant to purchase five shares of common stock and the Over-
Allotment Right, the Company used the relative fair value method to record 
the transaction. Accordingly, $2,668,000, $486,000 and $96,000 of the gross 
proceeds were attributed to the 40,625 shares of Series A Preferred Stock, 
the 203,125 common stock warrants and the Over-Allotment Right, 
respectively. Since 38,750 shares of Series A Preferred Stock were issued 
for an effective purchase price of $6.56 per share, which was lower than 
the fair market value of the common stock at the date of closing, the 
investors realized a beneficial conversion feature of approximately 
$131,750. Accordingly, the beneficial conversion feature and the relative 
fair value of the warrants and Over-Allotment Right have been recorded as 
an increase to additional paid-in capital. The beneficial conversion 
feature was immediately accreted. 

Common Stock Warrants - The Company has issued common stock warrants in 
connection with certain financings.  All warrants are currently exercisable 
and the following table summarizes information about common stock warrants 
outstanding to lenders and investors at September 30, 2004: 



Fiscal Year             Number       Weighted-Average      Expiration
  Granted             Outstanding     Exercise Price          Date
-----------           -----------    ----------------      ----------

                                                 
    2003                 25,000           $6.89           June 10, 2008
    2004                225,000            8.00           July 28, 2007
    2004                 31,500            8.00           July 28, 2008
    2004                193,750            8.00           May 7, 2007
    2004                  9,375            8.00           June 8, 2007
                        -------           -----

    Total               484,625           $7.94
                        =======           =====


Upon execution of the Loan Agreement on June 10, 2003, the Company issued 
warrants for the purchase of 25,000 shares of its common stock to Silicon 
Valley Bank at an initial exercise price of $6.89 per share.  The exercise 
price is subject to future adjustment under certain conditions, including 
but not limited to, 


  13


stock splits and stock dividends.  The fair value of the warrants on June 
10, 2003 was approximately $100,600, which was recorded as a deferred 
financing cost and is being amortized to interest expense over the life of 
the Loan Agreement.  Amortization expense for the three months ended 
September 30, 2004 and September 28, 2003 was $12,600.

In connection with the sale of the Convertible Subordinated Notes, the 
investors and the investment adviser received warrants to purchase 331,500 
shares of common stock, at an initial exercise price of $8.00 per share. 
The exercise price of the warrants is subject to adjustment in the event of 
stock splits, dividends and certain combinations.  The relative fair value 
of the warrants issued to the investors and to the investment adviser on 
July 28, 2003 was approximately $1,035,000 and $146,000, respectively.  The 
relative fair value of the warrants was recorded as an increase in 
additional paid-in capital and as an original issuance discount recorded 
against the carrying value of the Notes.  In December 2003, one of the 
investors exercised their warrants to purchase 75,000 shares of Parlex 
common stock and the Company received proceeds of $600,000.  The original 
issue discount is being amortized to interest expense over the four year 
life of the Note and totaled $72,300 for the three months ended September 
30, 2004.

In connection with the sale of the Series A Convertible Preferred Stock, 
the investors received common stock purchase warrants for an aggregate of 
203,125 shares of common stock at an initial exercise price of $8.00 per 
share.  The conversion price of the Preferred Stock and the exercise price 
of the Warrants are subject to adjustment in the event of stock splits, 
dividends and certain combinations.

Treasury Stock - Effective July 1, 2004, companies incorporated in 
Massachusetts became subject to the Massachusetts Business Corporation Act, 
Chapter 156D.  The new Act eliminates the concept of "treasury stock" and 
instead Section 6.31 of Chapter 156D provides that shares that are 
reacquired by a company become authorized but unissued shares.  
Accordingly, shares previously reported as treasury stock by the Company 
have been redesignated, at an aggregate cost of $1,037,625, as authorized 
but unissued shares.  This aggregate cost has been allocated to the common 
stock's par value and additional paid in capital.

9.    Revenue Recognition
      -------------------

Revenue on product sales is recognized when persuasive evidence of an 
agreement exists, the price is fixed or determinable, delivery has occurred 
and there is reasonable assurance of collection of the sales proceeds. The 
Company generally obtains written purchase authorizations from its 
customers for a specified amount of product, at a specified price and 
considers delivery to have occurred at the time title to the product passes 
to the customer.  Title passes to the customer according to the shipping 
terms negotiated between the Company and the customer.  License fees and 
royalty income are recognized when earned. 

10.   Stock-Based Compensation
      ------------------------

The Company accounts for stock-based compensation to employees and 
nonemployee directors in accordance with Accounting Principles Board 
("APB") Opinion No. 25 using the intrinsic-value method as permitted by 
Statement of Financial Accounting Standards ("SFAS") No. 123, "Accounting 
for Stock-Based Compensation".  Under the intrinsic value method, 
compensation associated with stock awards to employees and directors is 
determined as the difference, if any, between the current fair value of the 
underlying common stock on the date compensation is measured and the price 
the employee or director must pay to exercise the award.  The measurement 
date for employee awards is generally the date of grant.


  14


Had the Company used the fair-value method to measure compensation, the 
Company's net loss and basic and diluted net loss per share would have been 
as follows:



                                                                Three Months Ended
                                                      September 30, 2004    September 28, 2003

                                                                         
Net loss attributable to common stockholders               $ (866,309)         $(2,087,031)
Add stock-based compensation expense
 included in reported net loss                                      -                    -
Deduct stock-based compensation expense
 determined under the fair-value method                       (82,000)            (191,000)
                                                           ----------          -----------
Net loss - attributable to common stockholders
 - pro forma                                               $ (948,309)         $(2,278,031)
                                                           ==========          ===========

Basic and diluted net loss per share - as reported         $    (0.13)         $     (0.33)
Basic and diluted net loss per share - pro forma           $    (0.15)         $     (0.36)


The fair values of the options at the date of grant were estimated using 
the Black-Scholes option pricing model with the following assumptions:



                                                   Three Months Ended    Three Months Ended
                                                   September 30, 2004    September 28, 2003

                                                                       
Average risk-free interest rate                           2.9%                  2.4%
Expected life of option grants                         3.5 years             3.5 years
Expected volatility of underlying stock                   70%                   77%
Expected dividend rate                                   None                  None


The following is a summary of activity for all of the Company's stock 
option plans:



                                                       Three Months Ended
                                                       September 30, 2004

                                                                  Weighted-
                                                     Shares        Average
                                                     Under        Exercise
                                                     Option         Price

                                                             
Outstanding options at beginning of period           567,775       $12.54
  Granted                                            116,500         6.01
  Cancelled                                           17,500        12.06
  Exercised                                                -            -
                                                     -------       ------
Outstanding options at end of period                 666,775       $11.41
                                                     =======       ======
Exercisable options at end of period                 389,878       $13.52
                                                     =======       ======
Weighted average fair value of options
 granted during the period                                         $ 2.99
                                                                   ======



  15


The following table presents weighted average price and life information 
about significant option groups outstanding and exercisable at September 
30, 2004:



                               Options Outstanding                Options Exercisable
                    ----------------------------------------     ----------------------
                                    Weighted-
                                     Average       Weighted-                 Weighted-
                                    Remaining      Average                   Average
  Exercise            Number       Contractual     Exercise                  Exercise
   Prices           Outstanding    Life (Years)      Price       Number       Price

                                                               
$ 5.67 - $ 6.67       128,500          9.0           $ 6.01       12,000      $ 6.05
  8.39 -  10.48       135,000          8.4             9.04       46,250        9.43
 11.37 -  13.25       271,525          6.5            12.17      199,878       12.28
 15.50 -  16.25        66,250          4.8            16.18       66,250       16.18
 18.75 -  19.13        63,500          3.0            18.78       63,500       18.78
 22.00 -  22.00         2,000          5.6            22.00        2,000       22.00
                      -------          ---           ------      -------      ------
$ 5.67 - $22.00       666,775          6.9           $11.41      389,878      $13.52
                      =======          ===           ======      =======      ======


11.   Income Taxes
      ------------

Income taxes are recorded for interim periods based upon an estimated 
annual effective tax rate.  The Company's effective tax rate is impacted by 
the proportion of its estimated annual income being earned in domestic 
versus foreign tax jurisdictions, the generation of tax credits and the 
recording of a valuation allowance.

The Company performs an ongoing evaluation of the realizability of its net 
deferred tax assets.  As a result of its operating losses, uncertain future 
operating results, and past non-compliance with certain of its debt 
covenant requirements, the Company determined during fiscal 2003 that it is 
more likely than not that certain historic and current year income tax 
benefits will not be realized. Consequently, the Company established a 
valuation allowance against all of its U.S. net deferred tax assets and has 
not given recognition to these net tax assets in the accompanying financial 
statements at September 30, 2004.  Upon a favorable change in the 
operations and financial condition of the Company that results in a 
determination that it is more likely than not that all or a portion of the 
net deferred tax assets will be utilized, all or a portion of the valuation 
allowance previously provided for will be eliminated. 

12.   Net Loss Per Share
      ------------------

Basic net loss per share is calculated on the weighted-average number of 
common shares outstanding during the period. Diluted net loss per share is 
calculated on the weighted-average number of common shares and common share 
equivalents resulting from outstanding options and warrants except where 
such items would be antidilutive.

The net loss attributable to common stockholders for each period is as 
follows:



                                              Three Months Ended
                                   September 30, 2004    September 28, 2003

                                                      
Net loss                               $(798,727)           $(2,087,031)
Dividends accrued on Series A
 preferred stock                         (67,582)                     -
                                       ---------            -----------
Net loss attributable to common
 stockholders                          $(866,309)           $(2,087,031)



  16


Antidilutive shares were not included in the per-share calculations for the 
three months ended September 30, 2004 and September 28, 2003 due to the 
reported net losses for those periods.  Antidilutive shares totaled 
approximately 1,085,900 and 937,000 for the three months ended September 
30, 2004 and September 28, 2003, respectively.  All antidilutive shares 
relate to outstanding stock options except for 475,625 and 347,500 
antidilutive shares for the three months ended September 30, 2004 and 
September 28, 2003, respectively relating to warrants issued in connection 
with certain debt and equity financings (see Note 8).

13.   Comprehensive Loss
      ------------------

Comprehensive loss for the three months ended September 30, 2004 and 
September 28, 2003 is as follows:



                                              Three Months Ended
                                   September 30, 2004    September 28, 2003

                                                      
Net loss                               $(798,727)           $(2,087,031)

Other comprehensive income (loss):
  Foreign currency translation
 adjustments                              76,710                (57,575)
                                       ---------            -----------

Total comprehensive loss               $(722,017)           $(2,144,606)
                                       =========            ===========


At September 30, 2004 and June 30, 2004, the Company's accumulated other 
comprehensive loss pertains entirely to foreign currency translation 
adjustments.





Item 2.  Management's Discussion and Analysis of Financial Condition and
------------------------------------------------------------------------
         Results of Operations
         ---------------------

This Management's Discussion and Analysis of Financial Condition and 
Results of Operations should be read in conjunction with the financial 
information included in this Quarterly Report on Form 10-Q and with 
"Factors That May Affect Future Results" set forth on page 27.  The 
following discussion contains forward-looking statements within the meaning 
of the Private Securities Litigation Reform Act of 1995, and is subject to 
the safe-harbor created by such Act. Forward-looking statements express our 
expectations or predictions of future events or results.  They are not 
guarantees and are subject to many risks and uncertainties.  There are a 
number of factors - many beyond our control - that could cause actual 
events or results to be significantly different from those described in the 
forward-looking statement.  Any or all of our forward-looking statements in 
this report or in any other public statements we make may turn out to be 
wrong. Forward-looking statements can be identified by the fact that they 
do not relate strictly to historical or current facts.  They use words such 
as "anticipate," "estimate," "expect," "project," "intend," "plan," 
"believe" or words of similar meaning.  They may also use words such as 
"will," "would," "should," "could" or "may".  Our actual results could 
differ materially from the results contemplated by these forward-looking 
statements as a result of many factors, including those discussed below and 
elsewhere in this Quarterly Report on Form 10-Q.

Our significant accounting policies are more fully described in Note 2 to 
our consolidated financial statements in our Annual Report on Form 10-K for 
the year ended June 30, 2004.  However, certain of our accounting policies 
are particularly important to the portrayal of our financial position and 
results of operations and require the application of significant judgment 
by our management which subjects them to an inherent degree of uncertainty.  
In applying our accounting policies, our management uses its best judgment 
to determine the appropriate assumptions to be used in the determination of 
certain estimates. Those estimates are based on our historical experience, 
terms of existing contracts, our observance of trends in the industry, 
information provided by our customers, information available from other 
outside sources, and on various other factors that we believe to be 
appropriate under the circumstances. We believe that the critical 
accounting policies discussed below involve more complex management 
judgment due to the sensitivity of the methods, assumptions and estimates 
necessary in determining the related asset, liability, revenue and expense 
amounts.

Overview

We believe we are a leading supplier of flexible interconnects principally 
for sale to the automotive, telecommunications and networking, diversified 
electronics, military, home appliance, electronic identification, medical and 
computer markets.  We believe that our development of innovative materials 
and processes provides us with a competitive advantage in the markets in 
which we compete.  During the past three fiscal years, we have invested 
approximately $12.4 million in property and equipment and approximately $17.7 
million in research and development to develop materials and enhance our 
manufacturing processes.  We believe that these expenditures will help us to 
meet customer demand for our products, and enable us to continue to be a 
technological leader in the flexible interconnect industry.  Our research and 
development expenses are included in our cost of products sold. 

Over the past three years, we were adversely affected by the economic 
downturn and its impact on our key customers and markets.  In 2004, we 
experienced sales growth in several strategic markets, particularly in the 
second half of the fiscal year.  Growth in the medical, home appliance and 
military markets has helped to reduce domestic losses. Significant investment 
over the past three years has positioned us to capitalize on a rapidly 
expanding China electronic manufacturing industry. In 2004, our China 
operations revenues increased by over 65% with significant improvement in 
profitability. 

During fiscal years 2002, 2003 and 2004 we incurred operating losses of $35.3 
million and used cash to fund operations and working capital of $13.7 
million. We have taken certain steps to improve operating margins, including 
the closure of facilities, downsizing of our North American employee base, 
and transfer of our manufacturing operations to lower cost locations, such as 
the People's Republic of China. In addition, we have 


  18


worked closely with our lenders to manage through this difficult time and 
have obtained additional capital in 2003 and 2004 through sale-leasebacks of 
selected corporate assets, the issuance of convertible debt and preferred 
stock and the execution of new working capital borrowing agreements. As a 
result of the difficult economic environment, we have had difficulty 
maintaining compliance with the terms and conditions of certain of our 
financing facilities in prior years and throughout 2004.  At September 30, 
2004, however, we were in compliance with all financial covenants.  Based 
upon our recent improvement in financial performance, we are currently, and 
expect to remain, in compliance with all of our financial covenants.

We have $7.7 million in existing short-term debt, associated with our Chinese 
operations, that will be refinanced or repaid in 2005.  We believe that we 
will be able to obtain the necessary refinancing of this debt because of our 
history of successfully refinancing our short-term Chinese borrowings and our 
rapidly improving Chinese operating results.  In fiscal 2004, revenues from 
our Chinese operations grew 65%.  In the quarter ended September 30, 2004 
revenues from our Chinese operations grew 89% compared to the quarter ended 
September 28, 2003.  We expect continued revenue growth and improved 
profitability in China during fiscal 2005.  Failure to obtain the necessary 
refinancing of our short-term Chinese debt may have a material adverse impact 
on our operations.

Critical Accounting Policies

The U.S. Securities and Exchange Commission defines critical accounting 
policies as those that are, in management's view, most important to the 
portrayal of the company's financial condition and results of operations 
and most demanding of their judgment.  We believe the following policies to 
be critical to an understanding of our consolidated financial statements 
and the uncertainties associated with the complex judgments made by us that 
could impact our results of operations, financial position and cash flows.  
Our significant accounting policies are more fully described in our Annual 
Report on Form 10-K for the year ended June 30, 2004.

The preparation of consolidated financial statements requires that we make 
estimates and judgments that affect the reported amounts of assets, 
liabilities, revenues and expenses, and related disclosures.  On an ongoing 
basis, we evaluate our estimates, including those related to bad debts, 
inventories, property, plant and equipment, goodwill and other intangible 
assets, valuation of stock options and warrants, income taxes and other 
accrued expenses, including self-insured health insurance claims.  We base 
our estimates on historical experience and on various other assumptions 
that are believed to be reasonable under the circumstances, the results of 
which form the basis for making judgments about the carrying values of 
assets and liabilities that are not readily apparent from other sources.  
In applying our accounting policies, our management uses its best judgment 
to determine the appropriate assumptions to be used in the determination of 
certain estimates.  Actual results would differ from these estimates.

Revenue recognition and accounts receivable. We recognize revenue on product 
sales when persuasive evidence of an agreement exists, the price is fixed and 
determinable, delivery has occurred and there is reasonable assurance of 
collection of the sales proceeds.  We generally obtain written purchase 
authorizations from our customers for a specified amount of product, at a 
specified price and consider delivery to have occurred at the time title to 
the product passes to the customer. Title passes to the customer according to 
the shipping terms negotiated between the customer and us.  License fees and 
royalty income are recognized when earned.  We have demonstrated the ability 
to make reasonable and reliable estimates of product returns in accordance 
with SFAS No. 48 and of allowances for doubtful accounts based on significant 
historical experience.  We maintain allowances for doubtful accounts for 
estimated losses resulting from the inability of our customers to make 
required payments.  If the financial condition of our customers were to 
deteriorate, resulting in an impairment of their ability to make payments, 
additional allowances may be required.


  19


Inventories. We value our raw material inventory at the lower of the actual 
cost to purchase and/or manufacture the inventory or the current estimated 
market value of the inventory.  Work in process and finished goods are valued 
as a percentage of completed cost, not in excess of net realizable value. We 
regularly review our inventory and record a provision for excess or obsolete 
inventory based primarily on our estimate of expected and future product 
demand.  Our estimates of future product demand will differ from actual 
demand and, as such, our estimate of the provision required for excess and 
obsolete inventory will change, which we will record in the period such 
determination was made. Raw material, work in process and finished goods 
inventory associated with programs cancelled by customers are fully reserved 
for as obsolete.  Reductions in obsolescence reserves are recognized when 
realized through disposal of reserved items, either through sale or 
scrapping.

Goodwill. We recorded goodwill in connection with our acquisition of a 40% 
interest in Parlex Shanghai and our 1999 acquisition of Parlex Dynaflex 
Corporation ("Dynaflex").  We account for goodwill under the provisions of 
SFAS No.142, "Goodwill and Other Intangible Assets".  Under the provisions 
of SFAS No. 142, if an intangible asset is determined to have an indefinite 
useful life, it shall not be amortized until its useful life is determined 
to be no longer indefinite.  An intangible asset that is not subject to 
amortization shall be tested for impairment annually or more frequently if 
events or changes in circumstances indicate that the asset might be 
impaired. Goodwill is not amortized but is tested for impairment, for each 
reporting unit, on an annual basis and between annual tests in certain 
circumstances.  In accordance with the guidelines in SFAS No. 142, we 
determined we have one reporting unit.  We evaluate goodwill for impairment 
by comparing our market capitalization, as adjusted for a control premium, 
to our recorded net asset value. If our market capitalization, as adjusted 
for a control premium, is less than our recorded net asset value, we will 
further evaluate the implied fair value of our goodwill with the carrying 
amount of the goodwill, as required by SFAS No. 142, and we will record an 
impairment charge against the goodwill, if required, in our results of 
operations in the period such determination was made. Since our market 
capitalization, as adjusted, exceeded our recorded net asset value upon 
adoption of SFAS No. 142 and at the subsequent annual impairment analysis 
dates, we have concluded that no impairment adjustments were required at 
the time of adoption or at the annual impairment analysis date.  The 
carrying value of the goodwill was $1,157,510 at September 30, 2004 and 
June 30, 2004.  Based on the current recorded net asset value, we may be 
required to record a charge for the impairment of our goodwill in the 
future should our stock price consistently remain at a price of less than 
approximately $5.00 per share.

Income Taxes. We determine if our deferred tax assets and liabilities are 
realizable on an ongoing basis by assessing our valuation allowance and by 
adjusting the amount of such allowance, as necessary.  In the determination 
of the valuation allowance, we have considered future taxable income and the 
feasibility of tax planning initiatives.  Should we determine that it is more 
likely than not that we will realize certain of our net deferred tax assets 
for which we previously provided a valuation allowance, an adjustment would 
be required to reduce the existing valuation allowance. In addition, we 
operate within multiple taxing jurisdictions and are subject to audit in 
these jurisdictions. These audits can involve complex issues, which may 
require an extended period of time for resolution. Although we believe that 
we have adequately considered such issues, there is the possibility that the 
ultimate resolution of such issues could have an adverse effect on the 
results of our operations.

Off-Balance Sheet Arrangements. We have not created, and are not party to, 
any special-purpose or off-balance sheet entities for the purpose of raising 
capital, incurring debt or operating parts of our business that are not 
consolidated into our financial statements. We do not have any arrangements 
or relationships with entities that are not consolidated into our financial 
statements that are reasonably likely to materially affect our liquidity or 
the availability of capital resources, except as may be set forth below 
under "Liquidity and Capital Resources."  Our obligations under operating 
leases are disclosed in the Notes to our financial statements.


  20


Results of Operations
---------------------

The following table sets forth, for the periods indicated, selected items 
in our statements of operations as a percentage of total revenue. You 
should read the table and the discussion below in conjunction with our 
Condensed Consolidated Financial Statements and the Notes thereto.



                                              Three Months Ended
                                   September 30, 2004    September 28, 2003

                                                      
Total revenues                         100.0 %              100.0 %
Cost of products sold                   85.1 %               88.7 %
                                       -----                -----

Gross profit                            14.9 %               11.3 %
Selling, general and
 administrative expenses                14.6 %               19.0 %
                                       -----                -----

Operating income (loss)                  0.3 %               (7.7)%
Loss from operations before
 income taxes and minority
 interest                               (2.2)%              (10.3)%
                                       -----                -----
Net loss                                (2.5)%              (10.6)%
                                       -----                -----


Three Months Ended September 30, 2004 Compared to Three Months Ended
--------------------------------------------------------------------
September 28, 2003
------------------

Total Revenues.  Total revenues for the three months ended September 30, 
2004 were $31.5 million versus $19.7 million for the three months ended 
September 28, 2003.  This represents an increase of $11.8 million or 60%.  
Solid revenue growth was recorded in each of our lines of business.

Revenues from our China operations increased to $14.7 million from $7.8 
million in the prior year representing an 89% increase for the same period 
year over year.  Strong growth occurred in the computer and peripheral 
market leveraging automated surface mount assembly capabilities installed 
late in the prior quarter.  Adding surface mount assembly to base flex 
circuit manufacturing significantly increased the revenue per circuit 
during the period.  Increasing value-add capabilities such as automated 
surface mount assembly, remains core to our growth strategy.  Growth in 
China also occurred in several other markets including automotive and 
electronic identification.

Polymer thick film revenues totaled $9.5 million increasing 46% versus the 
same period of the prior year.  Revenues increases continue to be driven by 
accelerated growth in the medical market, particularly in disposable 
medical devices.  Strong performance occurred in both our United Kingdom 
and United States manufacturing operations.

Revenues in our Methuen, Massachusetts multilayer manufacturing operations 
increased 37% versus the same period of the prior year.  Steady growth in 
military /aerospace programs has contributed to an improved backlog of base 
business.  In July 2004, we began transitioning multilayer flex 
manufacturing from Delphi Corporation's Irvine, California facility to our 
Methuen operation under a strategic sourcing relationship.  We expect to 
increase shipments from this opportunity over the next several quarters.

Cost of Products Sold.  Cost of products sold was $26.8 million, or 85% of 
total revenues, for the three months ended September 30, 2004, versus $17.5 
million, or 89% of total revenues, for the three months ended September 28, 
2003.  Reduction in the cost of products sold as a percentage of total 
revenues, or correspondingly an improvement in our gross margin, was in 
large part driven by manufacturing volume increases.  Revenues increased 
60%, for the same period year over year, resulting in improved factory 
utilization and better absorption of fixed overhead costs.  Fixed and 
variable manufacturing overhead 


  21


decreased from 41% of revenues in the first quarter of fiscal 2003 to 31% 
of revenues for the current quarter.  In addition to improved utilization, 
overhead as a percentage of revenue was favorably impacted by a continued 
shift of manufacturing to our low cost China operations. 

Reductions in manufacturing overhead were in part offset by increases in 
material cost.  Raw material costs and in particular copper prices 
escalated more than 25% during the past year.  Similarly, base flexible 
materials such as polyimide rose substantially during the year with 
worldwide supply constraints.  In many cases this has forced increased 
pricing to our customers.  Long term supply commitments however, do not 
always permit price increases, at least in the short term.  Rising material 
costs continues to place adverse pressure on gross margins.

The Methuen multilayer operation continues to experience low capacity 
utilization and, correspondingly, significant unfavorable manufacturing 
variances.  Revenue in the multilayer operation was severely impacted by 
the rapid decline of the telecommunications network infrastructure market.  
In fiscal 2001 this market represented over 75% of multilayer revenues.  In 
the first quarter of fiscal 2005, revenues in this market were immaterial. 
Over the past two years we have sought to replace this revenue by targeting 
markets demanding complex North American design and manufacturing 
solutions.  We believe the military aerospace and medical markets represent 
two growing markets demanding such services.  In addition to a focused 
corporate sales effort targeting new business development, we have 
continued to evaluate opportunities to acquire business, particularly in 
the highly fragmented military aerospace market. In June 2004, we entered 
into a strategic sourcing agreement with Delphi Corporation.  Under the 
arrangement Delphi Corporation will transfer production of its multilayer 
flexible circuit manufacturing to our Methuen operation.  In the first 
quarter of fiscal 2005 we began manufacturing for Delphi Corporation 
although initial shipments only totaled approximately $190,000.  We expect 
manufacturing to increase significantly over the remainder of the 2005 
fiscal year improving facility utilization and further reducing multilayer 
operating losses.

Selling, General and Administrative Expenses.  Selling, general and 
administrative expenses were $4.6 million for the three months ended 
September 30, 2004 versus $3.7 million for the comparable period in the 
prior year.  Increases can be primarily attributed to higher commissions 
($300,000) on sharp increases in revenues, higher public company costs 
($200,000) including legal, audit and insurance, continued escalation of 
fringe costs ($100,000) in particular medical expenses, and infrastructure 
investment in China ($200,000).

Interest Income.  Interest income was $6,000 for the three months ended 
September 30, 2004 compared to $5,000 for the three months ended September 
28, 2003, and primarily consists of interest income on our cash balances.

Interest Expense.  Interest expense was $764,000 for the three months ended 
September 30, 2004 compared to $533,000 for the three months ended 
September 28, 2003.  Interest expense for the period ended September 30, 
2004 included $425,000 for amortized deferred financing costs and $69,000 
for interest payable in common stock related to issuance of convertible 
notes in July 2003.  The deferred financing costs are associated with the 
sale-leaseback of our Methuen, Massachusetts facility, the Loan Security 
Agreement and sale of convertible subordinated note.  The balance of the 
interest expense represents interest incurred on our short and long term 
bank borrowings and deferred compensation. 

Non operating income.  Non operating income was $0 for the three months 
ended September 30, 2004 versus $12,000 for the three months ended 
September 28, 2003.  Non operating income primarily represents currency 
exchange rate gains.


  22


Non operating expense.  Non operating expense was $26,000 for the three 
months ended September 30, 2004 compared to $200 for the three months ended 
September 28, 2003.  Non operating expense primarily represents currency 
exchange rate losses.

Our loss before income taxes and the minority interest in our Chinese joint 
venture, Parlex Shanghai, was $706,000 in the three months ended September 
30, 2004 compared to $2.0 million in the three months ended September 28, 
2003.  We own 90.1% of the equity interest in Parlex Shanghai and, 
accordingly, include Parlex Shanghai's results of operations, cash flows 
and financial position in our consolidated financial statements.

Income Taxes. Our effective tax rate was approximately 7% for the three 
months ended September 30, 2004 versus 0% for the three months ended 
September 28, 2003.  Our effective tax rate is impacted by the proportion 
of our estimated annual income being earned in domestic versus foreign tax 
jurisdictions, the generation of tax credits and the recording of any 
valuation allowance.  As a result of our history of operating losses, 
uncertain future operating results, and the past non-compliance with 
certain of our debt covenants requirements, which have subsequently been 
waived, we determined that it is more likely than not that certain historic 
and current year income tax benefits will not be realized.  Consequently, 
we recorded no income tax benefits on our U.S. operating losses during the 
three months ended September 30, 2004.  In fiscal 2003, we established a 
valuation allowance against all of our remaining net U.S. deferred tax 
assets.

Liquidity and Capital Resources
-------------------------------

As of September 30, 2004, we had approximately $2.5 million in cash and 
cash equivalents.

Net cash used by operations during the three months ended September 30, 
2004 was $987,000.  Net operating losses of $799,000 after adjustment for 
minority interest, interest payable in common stock, depreciation and 
amortization, provided $995,000 of operating cash.  Working capital 
consumed $2.0 million of cash.  Cash used for working capital included $3.9 
million for accounts receivable, $2.3 million for inventory, $3.9 million 
from accounts payable, and $242,000 from other working capital sources.  
Increases in accounts receivable were primarily driven by revenue growth.  
In addition, a pricing dispute with a major customer, which was resolved in 
October 2004, contributed $1 million to the increases in accounts 
receivable at September 30, 2004.  Inventory increases occurred in raw 
material, which includes connectors and assembly components ($1.5 million) 
and work in process ($600,000).  The growth in inventory is in part a 
function of our expanded value-add strategy.

Net cash provided by investing activities was $594,000 for the three months 
ended September 30, 2004, and was used to purchase capital equipment and 
other assets.  As of September 30, 2004, we have an additional $187,000 of 
capital equipment financed under our accounts payable.  We have implemented 
plans to control our capital expenditures in order to enhance cash flows.  
Cash provided by financing activities was $2.4 million for the three months 
ended September 30, 2004 including $2.5 million that represents the net 
repayments and borrowings on our bank debt.  Payments include $1.2 million 
to retire one of Parlex Shanghai's local short-term bank notes.

Improved financial performance in the first quarter of 2005 significantly 
reduced operating losses and cash used in operations.  Increased sales in 
the first quarter of 2005, however, have placed additional cash demands on 
working capital with growth in account receivables and inventory.  The 
strong credit ratings of our large OEM and EMS customer base have allowed 
us to successfully finance this growth through our asset based working 
capital lines of credit.  We recently completed stand alone financing for 
our China operations through a new line of credit with Bank of China which 
will allow us to continue financing our growth plans.  See "Factors That 
May Affect Future Results".


  23


Series A Convertible Preferred Stock - On June 8, 2004, we completed a 
private placement of 40,625 shares of Series A Convertible Preferred Stock 
and warrants entitling holders to purchase an aggregate of 203,125 shares 
of common stock at $80.00 per unit for proceeds of approximately 
$2,950,000, net of issuance costs of approximately $300,000.  In connection 
with the private placement, the investors received rights to purchase 
additional shares of the Series A Preferred Stock. For additional 
information relating to the Series A Convertible Preferred Stock, please 
see Note 8 to the Notes to Unaudited Condensed Consolidated Financial 
Statements.

Loan and Security Agreement (the "Loan Agreement") - We executed the Loan 
Agreement with Silicon Valley Bank on June 11, 2003.  The Loan Agreement 
provided Silicon Valley Bank with a secured interest in substantially all 
of our assets.  We may borrow up to $10,000,000, based on a borrowing base 
of eligible accounts receivable.  Borrowings may be used for working 
capital purposes only.  The Loan Agreement allows us to issue letters of 
credit, enter into foreign exchange forward contracts and incur obligations 
using the bank's cash management services up to an aggregate limit of 
$1,000,000, which reduces our availability for borrowings under the Loan 
Agreement.  The Loan Agreement contains certain restrictive covenants, 
including but not limited to, limitations on debt incurred by our foreign 
subsidiaries, acquisitions, sales and transfers of assets, and prohibitions 
against cash dividends, mergers and repurchases of stock without prior bank 
approval.  The Loan Agreement also has financial covenants, which among 
other things require us to maintain $750,000 in minimum cash balances or 
excess availability under the Loan Agreement.

On September 23, 2003, we executed a Modification Agreement (the 
"Modification Agreement") with Silicon Valley Bank.  The Modification 
Agreement increased the interest rate on borrowings to the bank's prime 
rate plus 1.5% and amended the financial covenants.  On February 18, 2004, 
we executed a Second Modification Agreement (the "Second Modification 
Agreement") with Silicon Valley Bank.  The Second Modification Agreement 
removed the fixed charge coverage ratio from the Loan Agreement and 
required us to report EBITDA of at least $50,000 on a three month trailing 
basis, beginning January 31, 2004.  The minimum EBITDA requirement was 
increased to $250,000 at June 30, 2004.  The Second Modification Agreement 
increased the interest rate on borrowings to the bank's prime rate plus 
2.0% (decreasing to prime plus 1.25% after two consecutive quarters of 
positive operating income and to prime plus 0.75% after two consecutive 
quarters of positive net income, respectively) and amended the financial 
covenants.  On March 28, 2004, we entered into a Third Loan Modification 
Agreement with Silicon Valley Bank, which permitted certain of our 
subsidiaries to increase the amount of indebtedness they could incur from 
$8 million to $13 million, so long as such indebtedness was without 
recourse to Parlex and our principal subsidiaries.  On May 10, 2004, we 
executed a Fourth Loan Modification Agreement (the "Fourth Modification 
Agreement") with Silicon Valley Bank.  The Fourth Modification Agreement 
changed the EBITDA requirement to $1.00 as of April 30, 2004 and May 31, 
2004 and $250,000 on a three month trailing basis beginning June 30, 2004. 
On June 25, 2004, we executed a Fifth Loan Modification Agreement (the 
"Fifth Modification Agreement") with Silicon Valley Bank. The Fifth 
Modification Agreement permitted certain of our subsidiaries to borrow up 
to $5,000,000 in the aggregate from the Bank of China. The Fifth 
Modification Agreement increased the interest rate on borrowings to the 
bank's prime rate (4.75% at September 30, 2004) plus 2.25% (decreasing to 
prime plus 1.25% after two consecutive quarters of positive operating 
income and to prime plus 0.75% after two consecutive quarters of positive 
net income, respectively). On September 24, 2004, we executed a Sixth Loan 
Modification Agreement with Silicon Valley Bank to extend the maturity date 
of the Loan Agreement from June 10, 2005 to July 11, 2005.  All other terms 
and conditions of the Loan Agreement remain the same. As of September 30, 
2004, we were in compliance with our financial covenants.  At September 30, 
2004, we had available borrowing capacity under the Loan Agreement of 
approximately $1.6 million. Since the available borrowing capacity exceeded 
$750,000 at September 30, 2004, none of our cash balance was subject to 
restriction at September 30, 2004.

The Loan Agreement includes both a subjective acceleration clause and a 
lockbox arrangement that requires all lockbox receipts to be used to pay 
down the revolving credit borrowings.  Accordingly, borrowings under the 
Loan Agreement have been classified as current liabilities in the 
accompanying consolidated 


  24


balance sheets as of September 30, 2004 and June 30, 2004 as required by 
Emerging Issues Task Force Issue No. 95-22, " Balance Sheet Classification 
of Borrowings Outstanding Under Revolving Credit Agreements that include 
both a Subjective Acceleration Clause and a Lockbox Arrangement".  However, 
such borrowings will be excluded from current liabilities in future periods 
and considered long-term obligations if : 1) such borrowings are refinanced 
on a long-term basis, 2) the subjective acceleration terms of the Loan 
Agreement are modified, or 3) such borrowings will not require the use of 
working capital within one year.

Parlex Shanghai Term Notes - On August 20, 2003, Parlex Shanghai entered 
into a short-term bank note, due August 20, 2004, bearing interest at 
5.841% and guaranteed by Parlex Interconnect.  The note was retired in 
August 2004.   On December 15, 2003, Parlex Shanghai entered into a short-
term bank note, due December 15, 2004, bearing interest at 5.31% and 
guaranteed by Parlex Interconnect.  Amounts outstanding under this short-
term note totaled $605,000 as of September 30, 2004.  On January 14, 2004, 
Parlex Shanghai entered into two short-term bank notes, due October 12, 
2004 for $725,000 and November 10, 2004 for $1.0 million, bearing interest 
at 5.31% and guaranteed by Parlex Interconnect.  On October 11, 2004, 
Parlex Shanghai renewed the bank note due October 12, 2004 for an 
additional six months.  We intend on renewing the bank note due November 
10, 2004 at similar terms and conditions.  On February 13, 2004 and March 
2, 2004, Parlex Shanghai entered into two short-term bank notes, due 
January 12, 2005 and March 1, 2005 respectively, bearing interest at 5.31% 
and guaranteed by Parlex Interconnect.  Amounts outstanding under these 
short-term notes as of September 30, 2004 totaled $3.8 million.  On March 
5, 2004, Parlex Shanghai entered into a short-term bank note, due January 
5, 2005, bearing interest at LIBOR plus 2.5% and guaranteed by Parlex 
Asia.  Amounts outstanding under this short-term note as of September 30, 
2004 totaled $1.5 million.  We believe that we will be able to obtain the 
necessary refinancing of our Parlex Shanghai short-term debt because of 
our history of successfully refinancing our Chinese debt and our improving 
operating results.

Parlex Interconnect Term Notes - On October 28, 2004, Parlex Interconnect 
entered into a $605,000 short-term bank note, due October 27, 2005, bearing 
interest at 5.31% and guaranteed by Parlex Shanghai.

Parlex Asia Banking Facility - On September 15, 2004, Parlex Asia entered 
into an agreement with the Bank of China for a $5 million banking facility 
guaranteed by Parlex. Under the terms of the banking facility, Parlex Asia 
may borrow up to $5 million based on a borrowing base of eligible account 
receivables. The banking facility bears interest at LIBOR plus 2%.  We 
anticipate utilizing borrowings from this financing for the refinancing of 
certain Parlex Shanghai term notes or for working capital needs.

Finance Obligation on Sale Leaseback of Methuen Facility - In June 2003, we 
entered into a sale-leaseback transaction pursuant to which we sold our 
corporate headquarters and manufacturing facility located in Methuen, 
Massachusetts (the "Methuen Facility") for a purchase price of $9,000,000.  
The purchase price consisted of $5,350,000 in cash at the closing, a 
promissory note in the amount of $2,650,000 (the "Note") and up to 
$1,000,000 in additional cash under the terms of an Earn Out Clause. In 
June 2004, we received $750,000 reducing the principal balance of the 
promissory note to $1,900,000. Under the terms of the Purchase and Sale 
Agreement, we simultaneously entered into a lease agreement relating to the 
Methuen Facility with a minimum lease term of 15 years.

As the repurchase option contained in the lease and the receipt of the Note 
from the buyer provide us with a continuing involvement in the Methuen 
Facility, we have accounted for the sale-leaseback of the Methuen Facility 
as a financing transaction. Accordingly, we continue to report the Methuen 
Facility as an asset and continue to record depreciation expense. We record 
all cash received under the transaction as a finance obligation. The Note 
and related interest thereon, and the $1,000,000 in additional cash under 
the terms of an Earn Out Clause, will be recorded as an increase to the 
finance obligation as cash payments are received. We record the principal 
portion of the monthly lease payments as a reduction to the finance 
obligation and the interest portion of the monthly lease payments is 
recorded as interest expense. The closing costs for the transaction have 
been capitalized and are being amortized as interest expense over the 
initial 15-year lease 


  25


term. Upon expiration of the repurchase option (June 30, 2015), we will 
reevaluate our accounting to determine whether a gain or loss should be 
recorded on this sale-leaseback transaction. 

Convertible Subordinated Notes - On July 28, 2003, we sold an aggregate 
$6,000,000 of our 7% convertible subordinated notes (the "Notes") with 
attached warrants to several institutional investors. We received net 
proceeds of approximately $5.5 million from the transaction, after 
deducting approximately $500,000 in finders' fees and other transaction 
expenses. Net proceeds were used to pay down amounts borrowed under our 
Loan Agreement and utilized for working capital needs. No principal 
payments are due until maturity on July 28, 2007. The Notes are unsecured.

The Notes bear interest at a fixed rate of 7%, payable quarterly in shares 
of our common stock. The number of shares of common stock to be issued is 
calculated by dividing the accrued quarterly interest by a conversion 
price, which was initially established at $8.00 per share.  The conversion 
price is subject to adjustment in the event of stock splits, dividends and 
certain combinations.

Interest expense is recorded quarterly based on the fair value of the 
common shares issued. Accordingly, interest expense may fluctuate from 
quarter to quarter. We have concluded that the interest feature does not 
constitute an embedded derivative as it does not currently meet the 
criteria for classification as a derivative. We recorded accrued interest 
payable on the Notes of $68,502 within stockholders' equity at September 
30, 2004, as the interest is required to be paid quarterly in the form of 
common stock. Based on the conversion price of $8.00 per common share, we 
issued a total of 48,717 shares of common stock in October 2003, and in 
January, April and July 2004 in satisfaction of the previously recorded 
interest.  We also issued 13,123 shares of common stock in October 2004 as 
payment for the interest accrued as of September 30, 2004.

The Notes contained a beneficial conversion feature reflecting an effective 
initial conversion price that was less than the fair market value of the 
underlying common stock on July 28, 2003. The fair value of the beneficial 
conversion feature was approximately $1,035,000, which has been recorded as 
an increase to additional paid-in capital and as an original issue discount 
on the Notes which is being amortized to interest expense over the four 
year life of the Notes.

After two years from the date of issuance, we have the right to redeem all, 
but not less than all, of the Notes at 100% of the remaining principal of 
Notes then outstanding, plus all accrued and unpaid interest, under certain 
conditions. After three years from the date of issuance, the holder of any 
of the Notes may require us to redeem the Notes in whole, but not in part. 
Such redemption shall be at 100% of the remaining principal of such Notes, 
plus all accrued and unpaid interest. In the event of a Change in Control 
(as defined therein), the holder has the option to require that the Notes 
be redeemed in whole (but not in part), at 120% of the outstanding unpaid 
principal amount, plus all unpaid accrued interest.

In response to the worldwide downturn in the electronics industry, we have 
taken a series of actions to reduce operating expenses and to restructure 
operations, consisting primarily of reductions in workforce and 
consolidation of manufacturing operations.  During 2004, we transferred our 
high volume automated surface mount assembly line from our Cranston, Rhode 
Island facility to China.  In August 2004, we announced a new strategic 
relationship with Delphi Corporation to supply all multilayer flex and 
rigid flex circuits which were previously manufactured by Delphi 
Corporation in its Irvine, California facility.  We continue to implement 
plans to control operating expenses, inventory levels, and capital 
expenditures as well as manage accounts payable and accounts receivable to 
enhance cash flow and return us to profitability. Our plans include the 
following actions: 1) continuing to consolidate manufacturing facilities; 
2) continuing to transfer certain manufacturing processes from our domestic 
operations to lower cost international manufacturing locations, primarily 
those in the People's Republic of China; 3) expanding our products in the 
home appliance, laptop computer, medical, military and aerospace, and 
electronic identification markets; 4) continuing to monitor general and 
administrative expenses; and 5) continuing to evaluate opportunities to 


  26


improve capacity utilization by either acquiring multilayer flexible 
circuit businesses or entering into strategic relationships for their 
production.

In fiscal years 2003 and 2004, we entered into a series of alternative 
financing arrangements to partially replace or supplement those currently 
in place in order to provide us with financing to support our current 
working capital needs.  Working capital requirements, particularly those to 
support the growth in our China operations, consumed $10.4 million of a 
total of $11.4 million of cash used in operations during 2004.  In 
September 2004, we secured a new $5 million asset based working capital 
agreement with the Bank of China which provides stand alone financing for 
our China operations. In addition, in May 2004 we received net proceeds of 
approximately $2.95 million from the sale of our Series A convertible 
preferred stock.  We continue to evaluate alternative financing 
opportunities to further improve our liquidity and to fund working capital 
needs.

We believe that our cash on hand and the cash expected to be generated from 
operations will be sufficient to enable us to meet our operating 
obligations through September 2005. If we require additional or new 
external financing to repay or refinance our existing financing obligations 
or fund our working capital requirements, we believe that we will be able 
to obtain such financing.  Failure to obtain such financing may have a 
material adverse impact on our operations.  At September 30, 2004, we were 
in compliance, and we expect to remain in compliance, with all of our 
financial covenants associated with our financing arrangements.

Factors That May Affect Future Results
--------------------------------------

Our prospects are subject to certain uncertainties and risks.  Our future 
results may differ materially from the current results and actual results 
could differ materially from those projected in the forward-looking 
statements as a result of certain risk factors, other one-time events and 
other important factors disclosed previously and from time to time in our 
other filings with the Securities and Exchange Commission.

If we cannot obtain additional financing when needed, we may experience a 
material adverse impact on our operations.

We may need to raise additional funds either through borrowings or further 
equity financing.  We may not be able to raise additional capital on 
reasonable terms, or at all.  The cash expected to be generated will not be 
sufficient to enable us to meet our financing and operating obligations 
over the next twelve months based on current growth plans.  If we cannot 
raise the required funds when needed, we may experience a material adverse 
impact on our operations.

Our business has been, and could continue to be, materially adversely 
affected as a result of general economic and market conditions.

We are subject to the effects of general global economic and market 
conditions.  Our operating results have been materially adversely affected 
as a result of recent unfavorable economic conditions and reduced 
electronics industry spending on both a domestic and worldwide basis.  
Though we have experienced some general market spending improvement during 
the past quarter, should market conditions not continue to improve, our 
business, results of operations or financial condition could continue to be 
materially adversely affected.

We have at times relied upon waivers from our lenders and amendments or 
modifications to our financing agreements to avoid any acceleration of our 
debt payments.  In the event that we are not in compliance with our 
financial covenants in the future, we cannot be certain our lenders will 
grant us waivers or execute amendments on terms, which are satisfactory to 
us.  If such waivers are not received, our debt is immediately callable.


  27


Since entering into our current loan arrangement with our primary lender, 
Silicon Valley Bank, in June of 2003, we have requested and received 
several waivers relating to our failure to comply with certain financial 
covenants under our loan arrangement.  In conjunction with the waivers, we 
have also executed several modifications of our loan arrangement, which 
have primarily resulted in easing our covenant compliance requirements, but 
have also increased our costs of borrowing.  Although we do not believe 
Silicon Valley Bank will exercise any right it may have to immediately call 
our debt if we fail to comply with our financial covenants, we cannot 
guarantee that they will not do so.  We are currently in compliance with 
all of our financial covenants, as amended.

The issuance of our shares upon conversion of outstanding convertible 
notes, conversion of preferred stock and upon exercise of outstanding 
warrants may cause significant dilution to our stockholders and may have an 
adverse impact on the market price of our common stock.

On July 28, 2003, we completed a private placement of our 7% convertible 
subordinated notes (and accompanying warrants) in an aggregate subscription 
amount of $6 million.  The conversion price of the convertible notes and 
the exercise price of the warrants is $8.00 per share.  In addition, on 
June 8, 2004, we completed a private placement of 40,625 shares of our 
Series A Convertible Preferred Stock (the "Preferred Stock") (and 
accompanying warrants), for $80.00 per share, or $3.25 million in the 
aggregate. Each share of Preferred Stock may be converted at any time at 
the option of the holder of the Preferred Stock for 10 shares of common 
stock, and the exercise price of the warrants is $8.00 per share.  For 
additional information relating to the sale of the convertible subordinated 
notes and related warrants, please see "Market for Registrant's Common 
Equity and Related Stockholder Matters - Recent Sales of Unregistered 
Securities - 7% Convertible Subordinated Notes and Warrants" in our Form 
10-K filing for the period ended June 30, 2004.  For additional information 
relating to the sale of Preferred Stock and related warrants, please see 
"Market for Registrant's Common Equity and Related Stockholder Matters - 
Recent Sales of Unregistered Securities - Series A Preferred Stock and 
Warrants" in our Form 10-K filing for the period ended June 30, 2004.

The issuance of our shares upon conversion of the convertible subordinated 
notes and/or Preferred Stock, and exercise of the warrants, and their 
resale by the holders thereof will increase our publicly traded shares.  
These re-sales could also depress the market price of our common stock. We 
will not control whether or when the holders of these securities elect to 
convert or exercise their securities for common stock.  In addition, the 
perceived risk of dilution may cause our stockholders to sell their shares, 
which would contribute to a downward movement in the stock price of our 
common stock.  Moreover, the perceived risk of dilution and the resulting 
downward pressure on our stock price could encourage investors to engage in 
short sales of our common stock.  By increasing the number of shares 
offered for sale, material amounts of short selling could further 
contribute to progressive price declines in our common stock.

Substantial leverage and debt service obligations may adversely affect us.

We have a substantial amount of indebtedness.  As of September 30, 2004, we 
had approximately $26.0 million of consolidated debt of which $15.4 million 
is due within one year.  Our substantial level of indebtedness increases 
the possibility that we may be unable to generate sufficient cash to pay 
when due the principal of, interest on, or other amounts due with respect 
to our indebtedness.  Approximately 34% of our outstanding indebtedness 
bears interest at floating rates.  As a result, our interest payment 
obligations on such indebtedness will increase if interest rates increase.

Our substantial leverage could have significant negative consequences on 
our financial condition, results of operations, and cash flows, including:

*     Impairing our ability to meet one or more of the financial ratios 
      contained in our debt agreements or to generate cash sufficient to 
      pay interest or principal, including periodic principal amortization 
      payments, 


  28


      which events could result in an acceleration of some or all of our 
      outstanding debt as a result of cross-default provisions;

*     Increasing our vulnerability to general adverse economic and industry 
      conditions;

*     Limiting our ability to obtain additional debt or equity financing;

*     Requiring the dedication of a substantial portion of our cash flow 
      from operations to service our debt, thereby reducing the amount of 
      our cash flow available for other purposes, including capital 
      expenditures;

*     Requiring us to sell debt or equity securities or to sell some of our 
      core assets, possibly on unfavorable terms, to meet payment 
      obligations;

*     Limiting our flexibility in planning for, or reacting to, changes in 
      our business and the industries in which we compete; and

*     Placing us at a possible competitive disadvantage with less leveraged 
      competitors and competitors that may have better access to capital 
      resources.

Our credit agreement contains restrictive covenants that could adversely 
affect our business by limiting our flexibility.

Our credit agreement imposes restrictions that affect, among other things, 
our ability to incur additional debt, pay dividends, sell assets, create 
liens, make capital expenditures and investments, merge or consolidate, 
enter into transactions with affiliates, and otherwise enter into certain 
transactions outside the ordinary course of business.  Our credit agreement 
also requires us to maintain specified financial ratios and meet certain 
financial tests.  Our ability to continue to comply with these covenants 
and restrictions may be affected by events beyond our control.  A breach of 
any of these covenants or restrictions would result in an event of default 
under our credit agreement.  Upon the occurrence of a breach, the lender 
under our credit agreement could elect to declare all amounts borrowed 
thereunder, together with accrued interest, to be due and payable, 
foreclose on the assets securing our credit agreement and/or cease to 
provide additional revolving loans or letters of credit, which would have a 
material adverse effect on us.

We have incurred losses in each of the last three years, and we may 
continue to incur losses.

We incurred net losses in each of the last three fiscal years.  We had net 
losses of $8.2 million in fiscal year 2004, $19.5 million in fiscal year 
2003 and $10.4 million in fiscal year 2002.  Our operations may not be 
profitable in the future.

If we cannot obtain additional financing when needed, we may not be able to 
expand our operations and invest adequately in research and development, 
which could cause us to lose customers and market share.

The development and manufacturing of flexible interconnects is capital 
intensive.  To remain competitive, we must continue to make significant 
expenditures for capital equipment, expansion of operations and research 
and development.  We expect that substantial capital will be required to 
expand our manufacturing capacity and fund working capital for anticipated 
growth.  We may need to raise additional funds either through borrowings or 
further equity financing.  We may not be able to raise additional capital 
on reasonable terms, or at all.  If we cannot raise the required funds when 
needed, we may not be able to satisfy the demands of existing and 
prospective customers and may lose revenue and market share.


  29


Our operating results fluctuate and may fail to satisfy the expectations of 
public market analysts and investors, causing our stock price to decline.

Our operating results have fluctuated significantly in the past and we 
expect our results to continue to fluctuate in the future.  Our results may 
fluctuate due to a variety of factors, including the timing and volume of 
orders from customers, the timing of introductions of and market acceptance 
of new products, changes in prices of raw materials, variations in 
production yields and general economic trends.  It is possible that in some 
future periods our results of operations may not meet or exceed the 
expectations of public market analysts and investors.  If this occurs, the 
price of our common stock is likely to decline.

Our quarterly results depend upon a small number of large orders received 
in each quarter, so the loss of any single large order could adversely 
impact quarterly results and cause our stock price to drop.

A substantial portion of our sales in any given quarter depends on 
obtaining a small number of large orders for products to be manufactured 
and shipped in the same quarter in which the orders are received.  Although 
we attempt to monitor our customers' needs, we often have limited knowledge 
of the magnitude or timing of future orders.  It is difficult for us to 
reduce spending on short notice on operating expenses such as fixed 
manufacturing costs, development costs and ongoing customer service.  As a 
result, a reduction in orders, or even the loss of a single large order, 
for products to be shipped in any given quarter could have a material 
adverse effect on our quarterly operating results.  This, in turn, could 
cause our stock price to decline.

Because we sell a substantial portion of our products to a limited number 
of customers, the loss of a significant customer or a substantial reduction 
in orders by any significant customer would adversely impact our operating 
results.

Historically we have sold a substantial portion of our products to a 
limited number of customers. Our 20 largest customers based on sales 
accounted for approximately 52% of total revenues in fiscal year 2004, 50% 
of total revenues in fiscal year 2003, and 44% in fiscal year 2002.

We expect that a limited number of customers will continue to account for a 
high percentage of our total revenues in the foreseeable future.  As a 
result, the loss of a significant customer or a substantial reduction in 
orders by any significant customer would cause our revenues to decline and 
have an adverse effect on our operating results.

If we are unable to respond effectively to the evolving technological 
requirements of customers, our products may not be able to satisfy the 
demands of existing and prospective customers and we may lose revenues and 
market share.

The market for our products is characterized by rapidly changing technology 
and continuing process development.  The future success of our business 
will depend in large part upon our ability to maintain and enhance our 
technological capabilities.  We will need to develop and market products 
that meet changing customer needs, and successfully anticipate or respond 
to technological changes on a cost-effective and timely basis.  There can 
be no assurance that the materials and processes that we are currently 
developing will result in commercially viable technological processes, or 
that there will be commercial applications for these technologies. In 
addition, we may not be able to make the capital investments required to 
develop, acquire or implement new technologies and equipment that are 
necessary to remain competitive.  If we fail to keep pace with 
technological change, our products may become less competitive or obsolete 
and we may lose customers and revenues.

Competing technologies may reduce demand for our products.


  30


Flexible circuit and laminated cable interconnects provide electrical 
connections between components in electrical systems and are used as a 
platform to support the attachment of electronic devices. While flexible 
circuits and laminated cables offer several advantages over competing 
printed circuit board and ceramic hybrid circuit technologies, our 
customers may consider changing their designs to use these alternative 
technologies in future applications.  If our customers switch to 
alternative technologies, our business, financial condition and results of 
operations could be materially adversely affected.  It is also possible 
that the flexible interconnect industry could encounter competition from 
new technologies in the future that render existing flexible interconnect 
technology less competitive or obsolete.

We are heavily dependent upon certain target markets for domestic 
manufacturing. A slowdown in these markets could have a material impact on 
domestic capacity utilization resulting in lower sales and gross margins.

We manufacture our products in seven facilities worldwide, including lower 
cost offshore locations in China.  However, a significant portion of our 
manufacturing is still performed domestically.  Domestic manufacturing may 
be at a competitive disadvantage with respect to price when compared to 
lower cost facilities in Asia and other locations.  While historically our 
competitors in these locations have produced less technologically advanced 
products, they continue to expand their capabilities.  Further, we have 
targeted markets that have historically sought domestic manufacturing, 
including the military and aerospace markets.  Should we be unsuccessful in 
maintaining our competitive advantage or should certain target markets also 
move production to lower cost offshore locations, our domestic sales will 
decline resulting in significant excess capacity and reduced gross margins.

A significant downturn in any of the sectors in which we sell products 
could result in a revenue shortfall.

We sell our flexible interconnect products principally to the automotive, 
telecommunications and networking, diversified electronics, military, home 
appliance, electronic identification and computer markets.  The worldwide 
electronics industry has seen a substantial downturn since 2001 impacting a 
number of our target markets.  Although we serve a variety of markets to 
avoid a dependency on any one sector, a significant further downturn in any 
of these market sectors could cause a material reduction in our revenues, 
which could be difficult to replace.

We rely on a limited number of suppliers, and any interruption in our 
primary sources of supply, or any significant increase in the prices of 
materials, chemicals or components, would have an adverse effect on our 
short-term operating results.

We purchase the bulk of our raw materials, process chemicals and components 
from a limited number of outside sources. In fiscal year 2004, we purchased 
approximately 21% of our materials from Tongxing, a Chinese gold plater, 
and Northfield Acquisition Co., doing business as Sheldahl, our two largest 
suppliers. We operate under tight manufacturing cycles with a limited 
inventory of raw materials.  As a result, although there are alternative 
sources of the materials that we purchase from our existing suppliers, any 
unanticipated interruption in supply from Tongxing or Sheldahl, or any 
significant increase in the prices of materials, chemicals or components, 
would have an adverse effect on our short-term operating results.

The additional expenses and risks related to our existing international 
operations, as well as any expansion of our global operations, could 
adversely affect our business.

We own a 90.1% equity interest in our investment in China, Parlex Shanghai, 
which manufactures and sells flexible circuits.  We also operate a facility 
in Mexico for use in the finishing, assembly and testing of flexible 
circuit and laminated cable products.  We have a facility in the United 
Kingdom where we manufacture polymer thick film flexible circuits and 
polymer thick film flexible circuits with surface 


  31


mounted components and intend to introduce production of laminated cable 
within the next year.  We will continue to explore appropriate expansion 
opportunities as demand for our products increases.

Manufacturing and sales operations outside the United States carry a number 
of risks inherent in international operations, including: imposition of 
governmental controls, regulatory standards and compulsory licensure 
requirements; compliance with a wide variety of foreign and U.S. import and 
export laws; currency fluctuations; unexpected changes in trade 
restrictions, tariffs and barriers; political and economic instability; 
longer payment cycles typically associated with foreign sales; difficulties 
in administering business overseas; foreign labor issues; wars and acts of 
terrorism; and potentially adverse tax consequences.  Although these issues 
have not materially impacted our revenues or operations to date, we cannot 
guarantee that they will not impact our revenues or operations in the 
future.

International expansion may require significant management attention, which 
could negatively affect our business.  We may also incur significant costs 
to expand our existing international operations or enter new international 
markets, which could increase operating costs and reduce our profitability.

We face significant competition, which could make it difficult for us to 
acquire and retain customers.

We face competition worldwide in the flexible interconnect market from a 
number of foreign and domestic providers, as well as from alternative 
technologies such as rigid printed circuits.  Many of our competitors are 
larger than we are and have greater financial resources.  New competitors 
could also enter our markets.  Our competitors may be able to duplicate our 
strategies, or they may develop enhancements to, or future generations of, 
products that could offer price or performance features that are superior 
to our products.  Competitive pressures could also necessitate price 
reductions, which could adversely affect our operating results.  In 
addition, some of our competitors are based in foreign countries and have 
cost structures and prices based on foreign currencies.  Accordingly, 
currency fluctuations could cause our dollar-priced products to be less 
competitive than our competitors' products priced in other currencies.

We will need to make a continued high level of investment in product 
research and development, sales and marketing and ongoing customer service 
and support in order to remain competitive.  We may not have sufficient 
resources to be able to make these investments.  Moreover, we may not be 
able to make the technological advances necessary to maintain our 
competitive position in the flexible interconnect market.

We face risks from fluctuations in the value of foreign currency versus the 
U.S. dollar and the cost of currency exchange. 

While we transact business predominantly in U.S. dollars, a large portion 
of our sales and expenses are denominated in foreign currencies, primarily 
the Chinese Renminbi ("RMB"), the basic unit of currency issued by the 
People's Bank of China.  Currently, our exposure to risk from foreign 
exchange is limited due to the fact that the People's Republic of China has 
fixed the exchange rate of the Renminbi to the U.S. dollar.  The value of 
the Renminbi is subject to changes in the PRC government's policies and 
depends to an extent on its domestic and international economic and 
political developments, as well as supply and demand in the local market.  
We cannot give any assurance that the Renminbi will continue to remain 
stable against the U.S. dollar and other foreign currencies.  Any 
devaluation of the Renminbi may adversely affect our results of operations.  
In addition, a small portion of our sales and expenses are denominated in 
Euros and the British Pound.  Changes in the relation of foreign currencies 
to the U.S. dollar will affect our cost of sales and operating margins and 
could result in exchange losses.  We do not enter into foreign exchange 
contracts to reduce our exposure to these risks. 

If we are unable to attract, retain and motivate key personnel, we may not 
be able to develop, sell and support our products and our business may lack 
strategic direction.


  32


We are dependent upon key members of our management team.  In addition, our 
future success will depend in large part upon our continuing ability to 
attract, retain and motivate highly qualified managerial, technical and 
sales personnel.  Competition for such personnel is intense, and there can 
be no assurance that we will be successful in hiring or retaining such 
personnel.  We currently maintain a key person life insurance policy in the 
amount of $1.0 million on Peter J. Murphy. If we lose the services of Mr. 
Murphy or one or more other key individuals, or are unable to attract 
additional qualified members of the management team, our ability to 
implement our business strategy may be impaired. If we are unable to 
attract, retain and motivate qualified technical and sales personnel, we 
may not be able to develop, sell and support our products.

If we are unable to protect our intellectual property, our competitive 
position could be harmed and our revenues could be adversely affected.

We rely on a combination of patent and trade secret laws and non-disclosure 
and other contractual agreements to protect our proprietary rights.  We own 
20 patents issued and have 8 patent applications pending in the United 
States and have several corresponding foreign patent applications pending. 
Our existing patents may not effectively protect our intellectual property 
and could be challenged by third parties, and our future patent 
applications, if any, may not be approved.  In addition, other parties may 
independently develop similar or competing technologies. Competitors may 
attempt to copy aspects of our products or to obtain and use information 
that we regard as proprietary.  If we fail to adequately protect our 
proprietary rights, our competitors could offer similar products using 
materials, processes or technologies developed by us, potentially harming 
our competitive position and our revenues.

If we become involved in a protracted intellectual property dispute, or one 
with a significant damages award or which requires us to cease selling some 
of our products, we could be subject to significant liability and the time 
and attention of our management could be diverted.

Although no claims have been asserted against us for infringement of the 
proprietary rights of others, we may be subject to a claim of infringement 
in the future.  An intellectual property lawsuit against us, if successful, 
could subject us to significant liability for damages and could invalidate 
our proprietary rights.  A successful lawsuit against us could also force 
us to cease selling, or redesign, products that incorporate the infringed 
intellectual property.  We could also be required to obtain a license from 
the holder of the intellectual property to use the infringed technology.  
We might not be able to obtain a license on reasonable terms, or at all.  
If we fail to develop a non-infringing technology on a timely basis or to 
license the infringed technology on acceptable terms, our revenues could 
decline and our expenses could increase.

We may, in the future, be required to initiate claims or litigation against 
third parties for infringement of our proprietary rights or to determine 
the scope and validity of our proprietary rights or the proprietary rights 
of competitors.  Litigation with respect to patents and other intellectual 
property matters could result in substantial costs and divert our 
management's attention from other aspects of our business.

Market prices of technology companies have been highly volatile, and our 
stock price may be volatile as well.

From time to time the U.S. stock market has experienced significant price 
and trading volume fluctuations, and the market prices for the common stock 
of technology companies in particular have been extremely volatile.  In the 
past, broad market fluctuations that have affected the stock price of 
technology companies have at times been unrelated or disproportionate to 
the operating performance of these companies.  Any significant fluctuations 
in the future might result in a material decline in the market price of our 
common stock.


  33


Following periods of volatility in the market price of a particular 
company's securities, securities class action litigation has often been 
brought against that company.  If we were to become involved in this type 
of litigation, we could incur substantial costs and diversion of 
management's attention, which could harm our business, financial condition 
and operating results.

The costs of complying with existing or future environmental regulations, 
and of curing any violations of these regulations, could increase our 
operating expenses and reduce our profitability.

We are subject to a variety of environmental laws relating to the storage, 
discharge, handling, emission, generation, manufacture, use and disposal of 
chemicals, solid and hazardous waste and other toxic and hazardous 
materials used to manufacture, or resulting from the process of 
manufacturing, our products.  We cannot predict the nature, scope or effect 
of future regulatory requirements to which our operations might be subject 
or the manner in which existing or future laws will be administered or 
interpreted.  Future regulations could be applied to materials, products or 
activities that have not been subject to regulation previously.  The costs 
of complying with new or more stringent regulations, or with more vigorous 
enforcement of these regulations, could be significant.

Environmental laws require us to maintain and comply with a number of 
permits, authorizations and approvals and to maintain and update training 
programs and safety data regarding materials used in our processes.  
Violations of these requirements could result in financial penalties and 
other enforcement actions.  We could also be required to halt one or more 
portions of our operations until a violation is cured. Although we attempt 
to operate in compliance with these environmental laws, we may not succeed 
in this effort at all times.  The costs of curing violations or resolving 
enforcement actions that might be initiated by government authorities could 
be substantial.

Undetected problems in our products could directly impair our financial 
results.

If flaws in design, production, assembly or testing of our products were to 
occur by us or our suppliers, we could experience a rate of failure in our 
products that would result in substantial repair or replacement costs and 
potential damage to our reputation.  Continued improvement in manufacturing 
capabilities, control of material and manufacturing quality, and costs and 
product testing, are critical factors in our future growth.  There can be 
no assurance that our efforts to monitor, develop, modify and implement 
appropriate test and manufacturing processes for our products will be 
sufficient to permit us to avoid a rate of failure in our products that 
results in substantial delays in shipment, significant repair or 
replacement costs, or potential damage to our reputation, any of which 
could have a material adverse effect on our business, results of operations 
or financial condition.

Our stock is thinly traded.

Our stock is thinly traded and you may have difficulty in reselling your 
shares quickly.  The low trading volume of our common stock is outside of 
our control, and we cannot guarantee that trading volume will increase in 
the near future.

We do not expect to pay dividends in the foreseeable future.

We have never paid cash dividends on our common stock and we do not expect 
to pay cash dividends on our common stock any time in the foreseeable 
future.  In addition, our current financing agreements prohibit the payment 
of dividends.  The future payment of dividends directly depends upon our 
future earnings, capital requirements, financial requirements and other 
factors that our board of directors will consider.  For the foreseeable 
future, we will use earnings from operations, if any, to finance our 
growth, and we will not pay dividends to our common stockholders.  You 
should not rely on an investment in our common stock if 


  34


you require dividend income.  The only return on your investment in our 
common stock, if any, would most likely come from any appreciation of our 
common stock. 

We may have exposure to additional income tax liabilities.

As a multinational corporation, we are subject to income taxes in both the 
United States and various foreign jurisdictions. Our domestic and 
international tax liabilities are subject to the allocation of revenues and 
expenses in different jurisdictions and the timing of recognizing revenues 
and expenses. Additionally, the amount of income taxes paid is subject to 
our interpretation of applicable tax laws in the jurisdictions in which we 
file.  From time to time, we are subject to income tax audits.  While we 
believe we have complied with all applicable income tax laws, there can be 
no assurance that a governing tax authority will not have a different 
interpretation of the law and assess us with additional taxes.  Should we 
be assessed with significant additional taxes, there could be a material 
adverse affect on our results of operations or financial condition.

We could use preferred stock to resist takeovers, and the issuance of 
preferred stock may cause additional dilution.

Our Articles of Organization authorizes the issuance of up to 1,000,000 
shares of preferred stock, of which 40,625 shares are issued and 
outstanding as a result of our preferred stock offering completed in June 
2004.  Our Articles of Organization gives our board of directors the 
authority to issue preferred stock without approval of our stockholders. We 
may issue additional shares of preferred stock to raise money to finance 
our operations. We may authorize the issuance of the preferred stock in one 
or more series.  In addition, we may set the terms of preferred stock, 
including:

*     dividend and liquidation preferences;

*     voting rights;

*     conversion privileges;

*     redemption terms; and

*     other privileges and rights of the shares of each authorized series.

The issuance of large blocks of preferred stock could possibly have a 
dilutive effect to our existing stockholders.  It can also negatively 
impact our existing stockholders' liquidation preferences.  In addition, 
while we include preferred stock in our capitalization to improve our 
financial flexibility, we could possibly issue our preferred stock to 
friendly third parties to preserve control by present management.  This 
could occur if we become subject to a hostile takeover that could 
ultimately benefit Parlex and Parlex's stockholders.

Item 3.  Quantitative and Qualitative Disclosures About Market Risk
-------------------------------------------------------------------

The following discussion about our market risk disclosures involves forward-
looking statements. Actual results could differ materially from those 
projected in the forward-looking statements. 

We are exposed to market risk related to changes in U.S. and foreign interest 
rates and fluctuations in exchange rates. We do not use derivative financial 
instruments.


  35


Interest Rate Risk

Our primary bank facility bears interest at our lender's prime rate plus 
2.25%.  We also have a subsidiary bank note for $1,500,000 at LIBOR plus 
2.5%.  The prime rate is affected by changes in market interest rates.  These 
variable rate lending facilities create exposure for us relating to interest 
rate risk; however, we do not believe our interest rate risk to be material.  
As of September 30, 2004, we had an outstanding balance under our primary 
bank facility of $7,355,000 and an outstanding balance of $1,500,000 under 
our subsidiary note.  A hypothetical 10% change in interest rates would 
impact interest expense by approximately $63,000 over the next fiscal year, 
and such amount would not have a material effect on our financial position, 
results of operations and cash flows. 

The remainder of our long-term debt bears interest at fixed rates and is 
therefore not subject to interest rate risk. 

Currency Risk

Sales of Parlex Shanghai, Parlex Interconnect, Poly-Flex Circuits Limited and 
Parlex Europe are typically denominated in the local currency, which is also 
each company's functional currency. This creates exposure to changes in 
exchange rates. The changes in the Chinese/U.S. and U.K./U.S. exchange rates 
may positively or negatively impact our sales, gross margins and retained 
earnings. Based upon the current volume of transactions in China and the 
United Kingdom and the stable nature of the exchange rate between China and 
the U.S., we do not believe the market risk is material. We do not engage in 
regular hedging activities to minimize the impact of foreign currency 
fluctuations. Parlex Shanghai and Parlex Interconnect had combined net assets 
as of September 30, 2004 of approximately $20.6 million. Poly-Flex Circuits 
Limited and Parlex Europe had combined net assets as of September 30, 2004 of 
approximately $5.9 million. We believe that a 10% change in exchange rates 
would not have a significant impact upon our financial position, results of 
operation or outstanding debt. As of September 30, 2004, Parlex Shanghai had 
outstanding debt of approximately $7.7 million. As of September 30, 2004, 
Poly-Flex Circuits Limited had no outstanding debt. 

Item 4.  Controls and Procedures
--------------------------------

Evaluation of Disclosure Controls and Procedures 

We maintain disclosure controls and procedures that are designed to ensure 
that information required to be disclosed in the reports that we are 
required to file under the Securities and Exchange Act of 1934 is recorded, 
processed, summarized and reported within the time periods specified in the 
SEC's rules and forms, and that such information is accumulated and 
communicated to our management, including our principal executive officer 
and our principal financial officer, as appropriate, to allow timely 
decisions regarding required disclosure. Management necessarily applied its 
judgment in assessing the costs and benefits of such controls and 
procedures, which, by their nature, can provide only reasonable assurance 
regarding management's control objectives. Management believes that there 
are reasonable assurances that our controls and procedures will achieve 
management's control objectives. 

We have carried out an evaluation, under the supervision and with the 
participation of our management, including our Chief Executive Officer and 
our Chief Financial Officer, of the effectiveness of the design and 
operation of our disclosure controls and procedures pursuant to Exchange 
Act Rule 13a-15 as of September 30, 2004.  Based upon the foregoing, our 
Chief Executive Officer and our Chief Financial Officer concluded that our 
disclosure controls and procedures are effective in timely alerting them to 
material information relating to Parlex (and its consolidated subsidiaries) 
required to be included in our Exchange Act reports. 


  36


Changes in Internal Controls Over Financial Reporting

There have been no changes in our internal control over financial reporting 
during our most recent fiscal quarter that have materially affected, or are 
reasonably likely to materially affect, our internal control over financial 
reporting.


  37


                         PART II - OTHER INFORMATION
                         ---------------------------

Item 6.  EXHIBITS

         Exhibits - See Exhibit Index to this report.


  38


                                 SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, 
the registrant has duly caused this report to be signed on its behalf by 
the undersigned thereunto duly authorized.

                                       PARLEX CORPORATION
                                       ------------------


                                       By: /s/ Peter J. Murphy
                                           --------------------------------
                                           Peter J. Murphy
                                           President and Chief Executive 
                                           Officer


                                       By: /s/ Jonathan R. Kosheff 
                                           --------------------------------
                                           Jonathan R. Kosheff
                                           Treasurer & CFO

                                           (Principal Accounting and 
                                           Financial Officer)


                                       November 12, 2004
                                       -----------------
                                             Date


  39


                                EXHIBIT INDEX

EXHIBIT      DESCRIPTION OF EXHIBIT


  10.1       Change of Control Agreement, dated July 21, 2004 by and 
             between Parlex Corporation and Thibaud LeSeguillon (filed 
             herewith).

  10.2       Change of Control Agreement, dated July 21, 2004 by and 
             between Parlex Corporation and Eric Zanin (filed herewith).

  10.3       Form of Stock Option Grant Agreement under Parlex 
             Corporation's 1989 Employees' Stock Option Plan (file 
             herewith).

  10.4       Form of Stock Option Grant Agreement under Parlex 
             Corporation's 1996 Outside Directors' Stock Option Plan (file 
             herewith).

  10.5       Form of Stock Option Grant Agreement under Parlex 
             Corporation's 2001 Employees' Stock Option Plan (file 
             herewith).

  31.1       Certification of Registrant's Chief Executive Officer required 
             by Rule 13a-14(a) (filed herewith)

  31.2       Certification of Registrant's Chief Financial Officer required 
             by Rule 13a-14(a) (filed herewith)

  32.1       Certification of Registrant's Chief Executive Officer pursuant 
             To 18 U.S.C. 1350 (furnished herewith)

  32.2       Certification of Registrant's Chief Financial Officer pursuant 
             To 18 U.S.C. 1350 (furnished herewith)


  40